id	sid	tid	token	lemma	pos
gra-819	1	1	introduction	introduction	NOUN
gra-819	1	2	the	the	DET
gra-819	1	3	term	term	NOUN
gra-819	1	4	chronic	chronic	ADJ
gra-819	1	5	spontaneous	spontaneous	ADJ
gra-819	1	6	urticaria	urticaria	NOUN
gra-819	1	7	(	(	PUNCT
gra-819	1	8	csu	csu	PROPN
gra-819	1	9	)	)	PUNCT
gra-819	1	10	is	be	AUX
gra-819	1	11	used	use	VERB
gra-819	1	12	to	to	PART
gra-819	1	13	describe	describe	VERB
gra-819	1	14	those	those	DET
gra-819	1	15	cases	case	NOUN
gra-819	1	16	in	in	ADP
gra-819	1	17	which	which	PRON
gra-819	1	18	the	the	DET
gra-819	1	19	cause	cause	NOUN
gra-819	1	20	could	could	AUX
gra-819	1	21	not	not	PART
gra-819	1	22	be	be	AUX
gra-819	1	23	determined	determine	VERB
gra-819	1	24	despite	despite	SCONJ
gra-819	1	25	of	of	ADP
gra-819	1	26	intensive	intensive	ADJ
gra-819	1	27	clinical	clinical	ADJ
gra-819	1	28	and	and	CCONJ
gra-819	1	29	laboratory	laboratory	NOUN
gra-819	1	30	investigations	investigation	NOUN
gra-819	1	31	.	.	PUNCT
gra-819	2	1	autoimmune	autoimmune	ADJ
gra-819	2	2	mechanisms	mechanism	NOUN
gra-819	2	3	have	have	AUX
gra-819	2	4	been	be	AUX
gra-819	2	5	proposed	propose	VERB
gra-819	2	6	to	to	PART
gra-819	2	7	cause	cause	VERB
gra-819	2	8	some	some	DET
gra-819	2	9	cases	case	NOUN
gra-819	2	10	of	of	ADP
gra-819	2	11	csu	csu	PROPN
gra-819	2	12	.	.	PUNCT
gra-819	3	1	this	this	PRON
gra-819	3	2	was	be	AUX
gra-819	3	3	supported	support	VERB
gra-819	3	4	by	by	ADP
gra-819	3	5	the	the	DET
gra-819	3	6	observation	observation	NOUN
gra-819	3	7	that	that	SCONJ
gra-819	3	8	an	an	DET
gra-819	3	9	intradermal	intradermal	ADJ
gra-819	3	10	injection	injection	NOUN
gra-819	3	11	of	of	ADP
gra-819	3	12	autologous	autologous	ADJ
gra-819	3	13	serum	serum	NOUN
gra-819	3	14	(	(	PUNCT
gra-819	3	15	autologous	autologous	ADJ
gra-819	3	16	serum	serum	NOUN
gra-819	3	17	skin	skin	NOUN
gra-819	3	18	test	test	NOUN
gra-819	3	19	)	)	PUNCT
gra-819	3	20	elicited	elicit	VERB
gra-819	3	21	immediate	immediate	ADJ
gra-819	3	22	wheal	wheal	ADJ
gra-819	3	23	and	and	CCONJ
gra-819	3	24	are	are	NOUN
gra-819	3	25	response	response	NOUN
gra-819	3	26	in	in	ADP
gra-819	3	27	60	60	NUM
gra-819	3	28	%	%	NOUN
gra-819	3	29	of	of	ADP
gra-819	3	30	patients	patient	NOUN
gra-819	3	31	with	with	ADP
gra-819	3	32	csu	csu	PROPN
gra-819	3	33	(	(	PUNCT
gra-819	3	34	1).later	1).later	NUM
gra-819	3	35	igg	igg	NOUN
gra-819	3	36	autoantibodies	autoantibody	NOUN
gra-819	3	37	directed	direct	VERB
gra-819	3	38	against	against	ADP
gra-819	3	39	ige	ige	PROPN
gra-819	3	40	or	or	CCONJ
gra-819	3	41	fceri	fceri	PROPN
gra-819	3	42	receptor	receptor	NOUN
gra-819	3	43	on	on	ADP
gra-819	3	44	ige	ige	PROPN
gra-819	3	45	were	be	AUX
gra-819	3	46	demonstrated	demonstrate	VERB
gra-819	3	47	and	and	CCONJ
gra-819	3	48	were	be	AUX
gra-819	3	49	found	find	VERB
gra-819	3	50	to	to	PART
gra-819	3	51	be	be	AUX
gra-819	3	52	the	the	DET
gra-819	3	53	cause	cause	NOUN
gra-819	3	54	of	of	ADP
gra-819	3	55	autoimmune	autoimmune	ADJ
gra-819	3	56	urticaria	urticaria	NOUN
gra-819	3	57	(	(	PUNCT
gra-819	3	58	2	2	NUM
gra-819	3	59	)	)	PUNCT
gra-819	3	60	.	.	PUNCT
gra-819	4	1	the	the	DET
gra-819	4	2	autoimmune	autoimmune	ADJ
gra-819	4	3	process	process	NOUN
gra-819	4	4	in	in	ADP
gra-819	4	5	csu	csu	PROPN
gra-819	4	6	overlaps	overlap	VERB
gra-819	4	7	with	with	ADP
gra-819	4	8	many	many	ADJ
gra-819	4	9	other	other	ADJ
gra-819	4	10	autoimmune	autoimmune	ADJ
gra-819	4	11	diseases	disease	NOUN
gra-819	4	12	,	,	PUNCT
gra-819	4	13	most	most	ADV
gra-819	4	14	common	common	ADJ
gra-819	4	15	amongst	amongst	ADP
gra-819	4	16	them	they	PRON
gra-819	4	17	is	be	AUX
gra-819	4	18	the	the	DET
gra-819	4	19	autoimmune	autoimmune	ADJ
gra-819	4	20	thyroid	thyroid	NOUN
gra-819	4	21	disease	disease	NOUN
gra-819	4	22	(	(	PUNCT
gra-819	4	23	3	3	NUM
gra-819	4	24	)	)	PUNCT
gra-819	4	25	.	.	PUNCT
gra-819	5	1	the	the	DET
gra-819	5	2	incidence	incidence	NOUN
gra-819	5	3	of	of	ADP
gra-819	5	4	thyroid	thyroid	NOUN
gra-819	5	5	autoantibodies	autoantibody	NOUN
gra-819	5	6	in	in	ADP
gra-819	5	7	patients	patient	NOUN
gra-819	5	8	with	with	ADP
gra-819	5	9	cu	cu	PROPN
gra-819	5	10	ranges	range	VERB
gra-819	5	11	from	from	ADP
gra-819	5	12	6.5	6.5	NUM
gra-819	5	13	%	%	NOUN
gra-819	5	14	57	57	NUM
gra-819	5	15	%	%	NOUN
gra-819	5	16	(	(	PUNCT
gra-819	5	17	4	4	NUM
gra-819	5	18	,	,	PUNCT
gra-819	5	19	5	5	NUM
gra-819	5	20	)	)	PUNCT
gra-819	5	21	.	.	PUNCT
gra-819	6	1	total	total	PROPN
gra-819	6	2	ige	ige	PROPN
gra-819	6	3	has	have	AUX
gra-819	6	4	been	be	AUX
gra-819	6	5	found	find	VERB
gra-819	6	6	to	to	PART
gra-819	6	7	be	be	AUX
gra-819	6	8	raised	raise	VERB
gra-819	6	9	in	in	ADP
gra-819	6	10	patients	patient	NOUN
gra-819	6	11	with	with	ADP
gra-819	6	12	cu	cu	PROPN
gra-819	6	13	.	.	PUNCT
gra-819	7	1	this	this	PRON
gra-819	7	2	is	be	AUX
gra-819	7	3	because	because	SCONJ
gra-819	7	4	of	of	ADP
gra-819	7	5	polyclonal	polyclonal	ADJ
gra-819	7	6	activation	activation	NOUN
gra-819	7	7	of	of	ADP
gra-819	7	8	b	b	NOUN
gra-819	7	9	cells	cell	NOUN
gra-819	7	10	in	in	ADP
gra-819	7	11	cu	cu	PROPN
gra-819	7	12	(	(	PUNCT
gra-819	7	13	6).thus	6).thus	NUM
gra-819	7	14	,	,	PUNCT
gra-819	7	15	autoimmune	autoimmune	ADJ
gra-819	7	16	markers	marker	NOUN
gra-819	7	17	like	like	ADP
gra-819	7	18	antinuclear	antinuclear	ADJ
gra-819	7	19	antibodies	antibody	NOUN
gra-819	7	20	(	(	PUNCT
gra-819	7	21	ana	ana	PROPN
gra-819	7	22	)	)	PUNCT
gra-819	7	23	,	,	PUNCT
gra-819	7	24	rheumatoid	rheumatoid	NOUN
gra-819	7	25	factor	factor	NOUN
gra-819	7	26	(	(	PUNCT
gra-819	7	27	rf	rf	NOUN
gra-819	7	28	)	)	PUNCT
gra-819	7	29	,	,	PUNCT
gra-819	7	30	antithyroid	antithyroid	ADJ
gra-819	7	31	peroxidase	peroxidase	PROPN
gra-819	7	32	antibodies	antibodie	VERB
gra-819	7	33	(	(	PUNCT
gra-819	7	34	anti	anti	ADJ
gra-819	7	35	-	-	ADJ
gra-819	7	36	tpo	tpo	NOUN
gra-819	7	37	ab	ab	NOUN
gra-819	7	38	)	)	PUNCT
gra-819	7	39	,	,	PUNCT
gra-819	7	40	autologous	autologous	ADJ
gra-819	7	41	serum	serum	NOUN
gra-819	7	42	skin	skin	NOUN
gra-819	7	43	test	test	NOUN
gra-819	7	44	(	(	PUNCT
gra-819	7	45	asst	asst	NOUN
gra-819	7	46	)	)	PUNCT
gra-819	7	47	and	and	CCONJ
gra-819	7	48	total	total	ADJ
gra-819	7	49	ige	ige	PROPN
gra-819	7	50	are	be	AUX
gra-819	7	51	important	important	ADJ
gra-819	7	52	investigations	investigation	NOUN
gra-819	7	53	in	in	ADP
gra-819	7	54	csu	csu	PROPN
gra-819	7	55	.	.	PUNCT
gra-819	8	1	characterization	characterization	NOUN
gra-819	8	2	of	of	ADP
gra-819	8	3	inammatory	inammatory	ADJ
gra-819	8	4	response	response	NOUN
gra-819	8	5	erythrocyte	erythrocyte	NOUN
gra-819	8	6	sedimentation	sedimentation	NOUN
gra-819	8	7	rate	rate	NOUN
gra-819	8	8	(	(	PUNCT
gra-819	8	9	esr	esr	PROPN
gra-819	8	10	)	)	PUNCT
gra-819	8	11	and	and	CCONJ
gra-819	8	12	c	c	NOUN
gra-819	8	13	reactive	reactive	ADJ
gra-819	8	14	protein	protein	NOUN
gra-819	8	15	(	(	PUNCT
gra-819	8	16	crp	crp	NOUN
gra-819	8	17	)	)	PUNCT
gra-819	8	18	are	be	AUX
gra-819	8	19	essential	essential	ADJ
gra-819	8	20	for	for	ADP
gra-819	8	21	an	an	DET
gra-819	8	22	insight	insight	NOUN
gra-819	8	23	into	into	ADP
gra-819	8	24	the	the	DET
gra-819	8	25	pathophysiology	pathophysiology	NOUN
gra-819	8	26	of	of	ADP
gra-819	8	27	the	the	DET
gra-819	8	28	disease	disease	NOUN
gra-819	8	29	as	as	ADV
gra-819	8	30	well	well	ADV
gra-819	8	31	as	as	ADP
gra-819	8	32	its	its	PRON
gra-819	8	33	activity	activity	NOUN
gra-819	8	34	,	,	PUNCT
gra-819	8	35	severity	severity	NOUN
gra-819	8	36	and	and	CCONJ
gra-819	8	37	diagnosis	diagnosis	NOUN
gra-819	8	38	/	/	SYM
gra-819	8	39	management	management	NOUN
gra-819	8	40	of	of	ADP
gra-819	8	41	infections	infection	NOUN
gra-819	8	42	and	and	CCONJ
gra-819	8	43	autoimmune	autoimmune	ADJ
gra-819	8	44	diseases	disease	NOUN
gra-819	8	45	in	in	ADP
gra-819	8	46	the	the	DET
gra-819	8	47	course	course	NOUN
gra-819	8	48	of	of	ADP
gra-819	8	49	chronic	chronic	ADJ
gra-819	8	50	urticaria	urticaria	NOUN
gra-819	8	51	(	(	PUNCT
gra-819	8	52	7	7	NUM
gra-819	8	53	)	)	PUNCT
gra-819	8	54	.	.	PUNCT
gra-819	9	1	infections	infection	NOUN
gra-819	9	2	can	can	AUX
gra-819	9	3	cause	cause	VERB
gra-819	9	4	urticaria	urticaria	NOUN
gra-819	9	5	by	by	ADP
gra-819	9	6	inducing	induce	VERB
gra-819	9	7	molecular	molecular	ADJ
gra-819	9	8	mimicry	mimicry	NOUN
gra-819	9	9	,	,	PUNCT
gra-819	9	10	hence	hence	ADV
gra-819	9	11	identication	identication	NOUN
gra-819	9	12	and	and	CCONJ
gra-819	9	13	management	management	NOUN
gra-819	9	14	of	of	ADP
gra-819	9	15	infections	infection	NOUN
gra-819	9	16	in	in	ADP
gra-819	9	17	patients	patient	NOUN
gra-819	9	18	of	of	ADP
gra-819	9	19	cu	cu	PROPN
gra-819	9	20	is	be	AUX
gra-819	9	21	essential	essential	ADJ
gra-819	9	22	(	(	PUNCT
gra-819	9	23	8)	8)	NUM
gra-819	9	24	.	.	PUNCT
gra-819	9	25	materials	material	NOUN
gra-819	9	26	and	and	CCONJ
gra-819	9	27	methods	method	NOUN
gra-819	9	28	we	we	PRON
gra-819	9	29	retrospectively	retrospectively	ADV
gra-819	9	30	evaluated	evaluate	VERB
gra-819	9	31	134	134	NUM
gra-819	9	32	patients	patient	NOUN
gra-819	9	33	of	of	ADP
gra-819	9	34	chronic	chronic	ADJ
gra-819	9	35	urticaria	urticaria	NOUN
gra-819	9	36	seen	see	VERB
gra-819	9	37	in	in	ADP
gra-819	9	38	allergy	allergy	PROPN
gra-819	9	39	clinic	clinic	PROPN
gra-819	9	40	of	of	ADP
gra-819	9	41	department	department	PROPN
gra-819	9	42	of	of	ADP
gra-819	9	43	dermatology	dermatology	NOUN
gra-819	9	44	,	,	PUNCT
gra-819	9	45	venereology	venereology	NOUN
gra-819	9	46	and	and	CCONJ
gra-819	9	47	leprosy	leprosy	NOUN
gra-819	9	48	at	at	ADP
gra-819	9	49	avbims	avbims	PROPN
gra-819	9	50	dr	dr	PROPN
gra-819	9	51	.	.	PROPN
gra-819	9	52	ram	ram	PROPN
gra-819	9	53	manohar	manohar	PROPN
gra-819	9	54	lohia	lohia	PROPN
gra-819	9	55	hospital	hospital	PROPN
gra-819	9	56	,	,	PUNCT
gra-819	9	57	after	after	ADP
gra-819	9	58	taking	take	VERB
gra-819	9	59	approval	approval	NOUN
gra-819	9	60	from	from	ADP
gra-819	9	61	recent	recent	ADJ
gra-819	9	62	2	2	NUM
gra-819	9	63	years	year	NOUN
gra-819	9	64	span	span	VERB
gra-819	9	65	instituitional	instituitional	ADJ
gra-819	9	66	ethical	ethical	PROPN
gra-819	9	67	board	board	NOUN
gra-819	9	68	.	.	PUNCT
gra-819	10	1	patients	patient	NOUN
gra-819	10	2	of	of	ADP
gra-819	10	3	acute	acute	ADJ
gra-819	10	4	urticaria	urticaria	NOUN
gra-819	10	5	(	(	PUNCT
gra-819	10	6	duration	duration	NOUN
gra-819	10	7	of	of	ADP
gra-819	10	8	urticaria<6	urticaria<6	NOUN
gra-819	10	9	weeks	week	NOUN
gra-819	10	10	)	)	PUNCT
gra-819	10	11	,	,	PUNCT
gra-819	10	12	physical	physical	ADJ
gra-819	10	13	urticaria	urticaria	NOUN
gra-819	10	14	(	(	PUNCT
gra-819	10	15	excluded	exclude	VERB
gra-819	10	16	with	with	ADP
gra-819	10	17	proper	proper	ADJ
gra-819	10	18	history	history	NOUN
gra-819	10	19	)	)	PUNCT
gra-819	10	20	,	,	PUNCT
gra-819	10	21	urticarial	urticarial	PROPN
gra-819	10	22	vasculitis	vasculitis	PROPN
gra-819	10	23	,	,	PUNCT
gra-819	10	24	children	child	NOUN
gra-819	10	25	less	less	ADJ
gra-819	10	26	than	than	ADP
gra-819	10	27	12	12	NUM
gra-819	10	28	years	year	NOUN
gra-819	10	29	,	,	PUNCT
gra-819	10	30	pregnant	pregnant	ADJ
gra-819	10	31	and	and	CCONJ
gra-819	10	32	lactating	lactate	VERB
gra-819	10	33	women	woman	NOUN
gra-819	10	34	were	be	AUX
gra-819	10	35	excluded	exclude	VERB
gra-819	10	36	.	.	PUNCT
gra-819	11	1	data	datum	NOUN
gra-819	11	2	were	be	AUX
gra-819	11	3	collected	collect	VERB
gra-819	11	4	regarding	regard	VERB
gra-819	11	5	,	,	PUNCT
gra-819	11	6	age	age	NOUN
gra-819	11	7	,	,	PUNCT
gra-819	11	8	sex	sex	NOUN
gra-819	11	9	,	,	PUNCT
gra-819	11	10	disease	disease	NOUN
gra-819	11	11	duration	duration	NOUN
gra-819	11	12	,	,	PUNCT
gra-819	11	13	severity	severity	NOUN
gra-819	11	14	and	and	CCONJ
gra-819	11	15	laboratory	laboratory	NOUN
gra-819	11	16	parameters	parameter	NOUN
gra-819	11	17	.	.	PUNCT
gra-819	12	1	we	we	PRON
gra-819	12	2	used	use	VERB
gra-819	12	3	urticaria	urticaria	NOUN
gra-819	12	4	activity	activity	NOUN
gra-819	12	5	score	score	NOUN
gra-819	12	6	(	(	PUNCT
gra-819	12	7	uas	uas	NOUN
gra-819	12	8	)	)	PUNCT
gra-819	12	9	to	to	PART
gra-819	12	10	assess	assess	VERB
gra-819	12	11	severity	severity	NOUN
gra-819	12	12	of	of	ADP
gra-819	12	13	the	the	DET
gra-819	12	14	disease	disease	NOUN
gra-819	12	15	autologus	autologus	NOUN
gra-819	12	16	serum	serum	NOUN
gra-819	12	17	(	(	PUNCT
gra-819	12	18	9	9	NUM
gra-819	12	19	)	)	PUNCT
gra-819	12	20	.	.	PUNCT
gra-819	13	1	skin	skin	NOUN
gra-819	13	2	test(asst	test(asst	PROPN
gra-819	13	3	)	)	PUNCT
gra-819	13	4	done	do	VERB
gra-819	13	5	for	for	ADP
gra-819	13	6	each	each	DET
gra-819	13	7	patients	patient	NOUN
gra-819	13	8	by	by	ADP
gra-819	13	9	injecting	inject	VERB
gra-819	13	10	intradermaly	intradermaly	NOUN
gra-819	13	11	of	of	ADP
gra-819	13	12	0.1	0.1	NUM
gra-819	13	13	ml	ml	NOUN
gra-819	13	14	each	each	PRON
gra-819	13	15	of	of	ADP
gra-819	13	16	autologous	autologous	ADJ
gra-819	13	17	serum	serum	NOUN
gra-819	13	18	,	,	PUNCT
gra-819	13	19	saline	saline	NOUN
gra-819	13	20	(	(	PUNCT
gra-819	13	21	negative	negative	ADJ
gra-819	13	22	control	control	NOUN
gra-819	13	23	)	)	PUNCT
gra-819	13	24	on	on	ADP
gra-819	13	25	the	the	DET
gra-819	13	26	volar	volar	ADJ
gra-819	13	27	aspect	aspect	NOUN
gra-819	13	28	of	of	ADP
gra-819	13	29	left	left	ADJ
gra-819	13	30	forearm	forearm	NOUN
gra-819	13	31	with	with	ADP
gra-819	13	32	a	a	DET
gra-819	13	33	gap	gap	NOUN
gra-819	13	34	of	of	ADP
gra-819	13	35	5	5	NUM
gra-819	13	36	cm	cm	NOUN
gra-819	13	37	between	between	ADP
gra-819	13	38	each	each	DET
gra-819	13	39	injection	injection	NOUN
gra-819	13	40	site	site	NOUN
gra-819	13	41	.	.	PUNCT
gra-819	14	1	after	after	ADP
gra-819	14	2	30	30	NUM
gra-819	14	3	minutes	minute	NOUN
gra-819	14	4	the	the	DET
gra-819	14	5	wheal	wheal	NOUN
gra-819	14	6	formed	form	VERB
gra-819	14	7	at	at	ADP
gra-819	14	8	each	each	DET
gra-819	14	9	injection	injection	NOUN
gra-819	14	10	site	site	NOUN
gra-819	14	11	were	be	AUX
gra-819	14	12	measured	measure	VERB
gra-819	14	13	at	at	ADP
gra-819	14	14	two	two	NUM
gra-819	14	15	perpendicular	perpendicular	ADJ
gra-819	14	16	diameters	diameter	NOUN
gra-819	14	17	(	(	PUNCT
gra-819	14	18	d1	d1	NOUN
gra-819	14	19	,	,	PUNCT
gra-819	14	20	d2	d2	PROPN
gra-819	14	21	)	)	PUNCT
gra-819	14	22	and	and	CCONJ
gra-819	14	23	the	the	DET
gra-819	14	24	average	average	NOUN
gra-819	14	25	of	of	ADP
gra-819	14	26	the	the	DET
gra-819	14	27	two	two	NUM
gra-819	14	28	was	be	AUX
gra-819	14	29	calculated	calculate	VERB
gra-819	14	30	.	.	PUNCT
gra-819	15	1	asst	asst	NOUN
gra-819	15	2	was	be	AUX
gra-819	15	3	considered	consider	VERB
gra-819	15	4	to	to	PART
gra-819	15	5	be	be	AUX
gra-819	15	6	positive	positive	ADJ
gra-819	15	7	if	if	SCONJ
gra-819	15	8	seruminduced	seruminduce	VERB
gra-819	15	9	wheal	wheal	NOUN
gra-819	15	10	had	have	VERB
gra-819	15	11	a	a	DET
gra-819	15	12	diameter	diameter	NOUN
gra-819	15	13	(	(	PUNCT
gra-819	15	14	average	average	NOUN
gra-819	15	15	of	of	ADP
gra-819	15	16	d	d	PROPN
gra-819	15	17	1	1	NUM
gra-819	15	18	and	and	CCONJ
gra-819	15	19	d	d	NOUN
gra-819	15	20	2	2	NUM
gra-819	15	21	)	)	PUNCT
gra-819	15	22	of	of	ADP
gra-819	15	23	≥1.5	≥1.5	PROPN
gra-819	15	24	mm	mm	PROPN
gra-819	15	25	as	as	ADP
gra-819	15	26	compared	compare	VERB
gra-819	15	27	to	to	ADP
gra-819	15	28	the	the	DET
gra-819	15	29	saline	saline	NOUN
gra-819	15	30	-	-	PUNCT
gra-819	15	31	induced	induce	VERB
gra-819	15	32	wheal	wheal	NOUN
gra-819	15	33	at	at	ADP
gra-819	15	34	30	30	NUM
gra-819	15	35	minutes	minute	NOUN
gra-819	15	36	(	(	PUNCT
gra-819	15	37	10	10	NUM
gra-819	15	38	)	)	PUNCT
gra-819	15	39	.	.	PUNCT
gra-819	16	1	various	various	ADJ
gra-819	16	2	serologic	serologic	ADJ
gra-819	16	3	autoimmune	autoimmune	NOUN
gra-819	16	4	and	and	CCONJ
gra-819	16	5	inammatory	inammatory	ADJ
gra-819	16	6	markers	marker	NOUN
gra-819	16	7	including	include	VERB
gra-819	16	8	,	,	PUNCT
gra-819	16	9	antiassessed	antiassesse	VERB
gra-819	16	10	by	by	ADP
gra-819	16	11	different	different	ADJ
gra-819	16	12	methods	method	NOUN
gra-819	16	13	nuclear	nuclear	ADJ
gra-819	16	14	antibodies	antibodie	VERB
gra-819	16	15	(	(	PUNCT
gra-819	16	16	ana	ana	PROPN
gra-819	16	17	)	)	PUNCT
gra-819	16	18	,	,	PUNCT
gra-819	16	19	rheumatoid	rheumatoid	NOUN
gra-819	16	20	factor	factor	NOUN
gra-819	16	21	(	(	PUNCT
gra-819	16	22	rf	rf	NOUN
gra-819	16	23	)	)	PUNCT
gra-819	16	24	,	,	PUNCT
gra-819	16	25	thyroid	thyroid	NOUN
gra-819	16	26	autoantibodies	autoantibody	NOUN
gra-819	16	27	-	-	NOUN
gra-819	16	28	thyroperoxidase	thyroperoxidase	NOUN
gra-819	16	29	(	(	PUNCT
gra-819	16	30	antitpo<50iu	antitpo<50iu	NUM
gra-819	16	31	/	/	SYM
gra-819	16	32	ml	ml	NOUN
gra-819	16	33	)	)	PUNCT
gra-819	16	34	,	,	PUNCT
gra-819	16	35	serum	serum	PROPN
gra-819	16	36	total	total	NOUN
gra-819	16	37	ige	ige	PROPN
gra-819	16	38	(	(	PUNCT
gra-819	16	39	female<175	female<175	PROPN
gra-819	16	40	,	,	PUNCT
gra-819	16	41	male<250iu	male<250iu	NOUN
gra-819	16	42	/	/	SYM
gra-819	16	43	ml	ml	NOUN
gra-819	16	44	)	)	PUNCT
gra-819	16	45	and	and	CCONJ
gra-819	16	46	c	c	NOUN
gra-819	16	47	-	-	PUNCT
gra-819	16	48	reactive	reactive	ADJ
gra-819	16	49	protein	protein	NOUN
gra-819	16	50	(	(	PUNCT
gra-819	16	51	crp	crp	NOUN
gra-819	16	52	)	)	PUNCT
gra-819	16	53	assessed	assess	VERB
gra-819	16	54	by	by	ADP
gra-819	16	55	elisa	elisa	PROPN
gra-819	16	56	.	.	PUNCT
gra-819	16	57	thyroid	thyroid	PROPN
gra-819	16	58	function	function	NOUN
gra-819	16	59	test	test	NOUN
gra-819	16	60	(	(	PUNCT
gra-819	16	61	tft	tft	ADV
gra-819	16	62	)	)	PUNCT
gra-819	16	63	by	by	ADP
gra-819	16	64	chemiluminesense	chemiluminesense	NOUN
gra-819	16	65	(	(	PUNCT
gra-819	16	66	vitros	vitros	PROPN
gra-819	16	67	eci	eci	PROPN
gra-819	16	68	,	,	PUNCT
gra-819	16	69	and	and	CCONJ
gra-819	16	70	jhonson	jhonson	PROPN
gra-819	16	71	and	and	CCONJ
gra-819	16	72	jhonson	jhonson	PROPN
gra-819	16	73	)	)	PUNCT
gra-819	16	74	anti	anti	ADJ
gra-819	16	75	-	-	ADJ
gra-819	16	76	streptolysin	streptolysin	ADJ
gra-819	16	77	antibodies	antibody	NOUN
gra-819	16	78	(	(	PUNCT
gra-819	16	79	aso	aso	PROPN
gra-819	16	80	)	)	PUNCT
gra-819	16	81	by	by	ADP
gra-819	16	82	latex	latex	PROPN
gra-819	16	83	agglutination	agglutination	PROPN
gra-819	16	84	method	method	NOUN
gra-819	16	85	.	.	PUNCT
gra-819	17	1	comple	comple	PROPN
gra-819	17	2	te	te	ADP
gra-819	17	3	haemogram	haemogram	PROPN
gra-819	18	1	and	and	CCONJ
gra-819	18	2	e	e	NOUN
gra-819	18	3	r	r	VERB
gra-819	18	4	y	y	PROPN
gra-819	18	5	th	th	X
gra-819	18	6	rocy	rocy	NOUN
gra-819	18	7	te	te	ADP
gra-819	18	8	sedimentation	sedimentation	NOUN
gra-819	18	9	(	(	PUNCT
gra-819	18	10	esr	esr	PROPN
gra-819	18	11	)	)	PUNCT
gra-819	18	12	,	,	PUNCT
gra-819	18	13	routine	routine	ADJ
gra-819	18	14	and	and	CCONJ
gra-819	18	15	microscopic	microscopic	ADJ
gra-819	18	16	examination	examination	NOUN
gra-819	18	17	of	of	ADP
gra-819	18	18	urine	urine	NOUN
gra-819	18	19	and	and	CCONJ
gra-819	18	20	stool	stool	NOUN
gra-819	18	21	examination	examination	NOUN
gra-819	18	22	for	for	ADP
gra-819	18	23	ova	ova	NOUN
gra-819	18	24	and	and	CCONJ
gra-819	18	25	cyst	cyst	NOUN
gra-819	18	26	were	be	AUX
gra-819	18	27	done	do	VERB
gra-819	18	28	for	for	ADP
gra-819	18	29	each	each	DET
gra-819	18	30	participant	participant	NOUN
gra-819	18	31	.	.	PUNCT
gra-819	19	1	statistical	statistical	ADJ
gra-819	19	2	analysis	analysis	NOUN
gra-819	19	3	for	for	ADP
gra-819	19	4	demographic	demographic	ADJ
gra-819	19	5	and	and	CCONJ
gra-819	19	6	other	other	ADJ
gra-819	19	7	clinical	clinical	ADJ
gra-819	19	8	variables	variable	NOUN
gra-819	19	9	we	we	PRON
gra-819	19	10	use	use	VERB
gra-819	19	11	descriptive	descriptive	ADJ
gra-819	19	12	statistics	statistic	NOUN
gra-819	19	13	,	,	PUNCT
gra-819	19	14	using	use	VERB
gra-819	19	15	mean	mean	PROPN
gra-819	19	16	±	±	NUM
gra-819	19	17	standard	standard	ADJ
gra-819	19	18	deviation	deviation	NOUN
gra-819	19	19	and	and	CCONJ
gra-819	19	20	percentage	percentage	NOUN
gra-819	19	21	(	(	PUNCT
gra-819	19	22	frequency	frequency	NOUN
gra-819	19	23	)	)	PUNCT
gra-819	19	24	.	.	PUNCT
gra-819	20	1	we	we	PRON
gra-819	20	2	compared	compare	VERB
gra-819	20	3	between	between	ADP
gra-819	20	4	all	all	PRON
gra-819	20	5	clinical	clinical	ADJ
gra-819	20	6	with	with	ADP
gra-819	20	7	laboratory	laboratory	NOUN
gra-819	20	8	variables	variable	NOUN
gra-819	20	9	by	by	ADP
gra-819	20	10	using	use	VERB
gra-819	20	11	anova	anova	PROPN
gra-819	20	12	.	.	PUNCT
gra-819	21	1	pearson	pearson	PROPN
gra-819	21	2	correlation	correlation	NOUN
gra-819	21	3	was	be	AUX
gra-819	21	4	used	use	VERB
gra-819	21	5	to	to	ADP
gra-819	21	6	nd	nd	ADJ
gra-819	21	7	correlation	correlation	NOUN
gra-819	21	8	of	of	ADP
gra-819	21	9	these	these	DET
gra-819	21	10	lab	lab	NOUN
gra-819	21	11	and	and	CCONJ
gra-819	21	12	clinical	clinical	ADJ
gra-819	21	13	variables	variable	NOUN
gra-819	21	14	.	.	PUNCT
gra-819	22	1	a	a	DET
gra-819	22	2	p	p	NOUN
gra-819	22	3	value	value	NOUN
gra-819	22	4	of	of	ADP
gra-819	22	5	<	<	NOUN
gra-819	22	6	0.05	0.05	NUM
gra-819	22	7	was	be	AUX
gra-819	22	8	considered	consider	VERB
gra-819	22	9	as	as	ADP
gra-819	22	10	statically	statically	ADV
gra-819	22	11	signicant	signicant	ADJ
gra-819	22	12	.	.	PUNCT
gra-819	23	1	we	we	PRON
gra-819	23	2	used	use	VERB
gra-819	23	3	spss	spss	PROPN
gra-819	23	4	soft	soft	ADJ
gra-819	23	5	version	version	NOUN
gra-819	23	6	20.0	20.0	NUM
gra-819	23	7	.	.	PUNCT
gra-819	24	1	results	result	NOUN
gra-819	24	2	of	of	ADP
gra-819	24	3	the	the	DET
gra-819	24	4	134	134	NUM
gra-819	24	5	patients	patient	NOUN
gra-819	24	6	with	with	ADP
gra-819	24	7	chronic	chronic	ADJ
gra-819	24	8	spontaneous	spontaneous	ADJ
gra-819	24	9	urticaria	urticaria	NOUN
gra-819	24	10	92(68.7	92(68.7	NUM
gra-819	24	11	%	%	NOUN
gra-819	24	12	)	)	PUNCT
gra-819	24	13	were	be	AUX
gra-819	24	14	female	female	ADJ
gra-819	24	15	,	,	PUNCT
gra-819	24	16	42(31.3	42(31.3	NUM
gra-819	24	17	%	%	NOUN
gra-819	24	18	)	)	PUNCT
gra-819	24	19	male	male	NOUN
gra-819	24	20	with	with	ADP
gra-819	24	21	the	the	DET
gra-819	24	22	average	average	ADJ
gra-819	24	23	age	age	NOUN
gra-819	24	24	of	of	ADP
gra-819	24	25	35	35	NUM
gra-819	24	26	year	year	NOUN
gra-819	24	27	(	(	PUNCT
gra-819	24	28	14yrs-72yrs	14yrs-72yrs	NUM
gra-819	24	29	)	)	PUNCT
gra-819	24	30	.	.	PUNCT
gra-819	25	1	the	the	DET
gra-819	25	2	duration	duration	NOUN
gra-819	25	3	of	of	ADP
gra-819	25	4	the	the	DET
gra-819	25	5	onset	onset	NOUN
gra-819	25	6	of	of	ADP
gra-819	25	7	disease	disease	NOUN
gra-819	25	8	was	be	AUX
gra-819	25	9	average	average	ADJ
gra-819	25	10	38	38	NUM
gra-819	25	11	months	month	NOUN
gra-819	25	12	(	(	PUNCT
gra-819	25	13	2	2	NUM
gra-819	25	14	360months	360months	NUM
gra-819	25	15	)	)	PUNCT
gra-819	25	16	.	.	PUNCT
gra-819	26	1	urticaria	urticaria	NOUN
gra-819	26	2	activity	activity	NOUN
gra-819	26	3	score	score	NOUN
gra-819	26	4	was	be	AUX
gra-819	26	5	found	find	VERB
gra-819	26	6	to	to	PART
gra-819	26	7	be	be	AUX
gra-819	26	8	of	of	ADP
gra-819	26	9	moderate	moderate	ADJ
gra-819	26	10	grade	grade	NOUN
gra-819	26	11	among	among	ADP
gra-819	26	12	84(62.7	84(62.7	NUM
gra-819	26	13	%	%	NOUN
gra-819	26	14	)	)	PUNCT
gra-819	26	15	,	,	PUNCT
gra-819	26	16	severe	severe	ADJ
gra-819	26	17	grade	grade	NOUN
gra-819	26	18	31(23.1	31(23.1	NUM
gra-819	26	19	%	%	NOUN
gra-819	26	20	)	)	PUNCT
gra-819	26	21	and	and	CCONJ
gra-819	26	22	mild	mild	ADJ
gra-819	26	23	grade	grade	NOUN
gra-819	26	24	19(4.2	19(4.2	NUM
gra-819	26	25	%	%	NOUN
gra-819	26	26	)	)	PUNCT
gra-819	26	27	.	.	PUNCT
gra-819	27	1	autologus	autologus	NOUN
gra-819	27	2	serum	serum	PROPN
gra-819	27	3	skin	skin	NOUN
gra-819	27	4	test	test	NOUN
gra-819	27	5	(	(	PUNCT
gra-819	27	6	asst	asst	NOUN
gra-819	27	7	)	)	PUNCT
gra-819	27	8	was	be	AUX
gra-819	27	9	positive	positive	ADJ
gra-819	27	10	in	in	ADP
gra-819	27	11	40(29.9	40(29.9	NUM
gra-819	27	12	%	%	NOUN
gra-819	27	13	)	)	PUNCT
gra-819	27	14	.	.	PUNCT
gra-819	28	1	among	among	ADP
gra-819	28	2	40	40	NUM
gra-819	28	3	,	,	PUNCT
gra-819	28	4	to	to	PART
gra-819	28	5	evaluate	evaluate	VERB
gra-819	28	6	the	the	DET
gra-819	28	7	association	association	NOUN
gra-819	28	8	between	between	ADP
gra-819	28	9	clinical	clinical	ADJ
gra-819	28	10	parameters	parameter	NOUN
gra-819	28	11	of	of	ADP
gra-819	28	12	chronic	chronic	ADJ
gra-819	28	13	urticaria	urticaria	NOUN
gra-819	28	14	and	and	CCONJ
gra-819	28	15	various	various	ADJ
gra-819	28	16	biomarkers	biomarker	NOUN
gra-819	28	17	original	original	ADJ
gra-819	28	18	research	research	NOUN
gra-819	28	19	paper	paper	NOUN
gra-819	28	20	dr	dr	PROPN
gra-819	28	21	seema	seema	PROPN
gra-819	28	22	rani	rani	PROPN
gra-819	28	23	*	*	PUNCT
gra-819	28	24	associate	associate	PROPN
gra-819	28	25	professor	professor	NOUN
gra-819	28	26	,	,	PUNCT
gra-819	28	27	department	department	NOUN
gra-819	28	28	of	of	ADP
gra-819	28	29	dermatology	dermatology	NOUN
gra-819	28	30	,	,	PUNCT
gra-819	28	31	abvims	abvim	VERB
gra-819	28	32	,	,	PUNCT
gra-819	28	33	dr	dr	PROPN
gra-819	28	34	rmlh	rmlh	PROPN
gra-819	28	35	,	,	PUNCT
gra-819	28	36	new	new	PROPN
gra-819	28	37	delhi	delhi	PROPN
gra-819	28	38	*	*	SYM
gra-819	28	39	corresponding	correspond	VERB
gra-819	28	40	author	author	NOUN
gra-819	28	41	dermatology	dermatology	NOUN
gra-819	28	42	introduction	introduction	NOUN
gra-819	28	43	:	:	PUNCT
gra-819	28	44	causes	cause	NOUN
gra-819	28	45	of	of	ADP
gra-819	28	46	chronic	chronic	ADJ
gra-819	28	47	urticaria	urticaria	NOUN
gra-819	28	48	(	(	PUNCT
gra-819	28	49	cu	cu	NOUN
gra-819	28	50	)	)	PUNCT
gra-819	28	51	remain	remain	VERB
gra-819	28	52	obscure	obscure	ADJ
gra-819	28	53	.	.	PUNCT
gra-819	29	1	laboratory	laboratory	NOUN
gra-819	29	2	parameters	parameter	NOUN
gra-819	29	3	or	or	CCONJ
gra-819	29	4	biomarkers	biomarker	NOUN
gra-819	29	5	can	can	AUX
gra-819	29	6	be	be	AUX
gra-819	29	7	a	a	DET
gra-819	29	8	predictor	predictor	NOUN
gra-819	29	9	of	of	ADP
gra-819	29	10	duration	duration	NOUN
gra-819	29	11	and	and	CCONJ
gra-819	29	12	severity	severity	NOUN
gra-819	29	13	of	of	ADP
gra-819	29	14	urticaria	urticaria	NOUN
gra-819	29	15	.	.	PUNCT
gra-819	30	1	objective	objective	NOUN
gra-819	30	2	:	:	PUNCT
gra-819	30	3	the	the	DET
gra-819	30	4	aim	aim	NOUN
gra-819	30	5	of	of	ADP
gra-819	30	6	this	this	DET
gra-819	30	7	study	study	NOUN
gra-819	30	8	was	be	AUX
gra-819	30	9	to	to	PART
gra-819	30	10	evaluate	evaluate	VERB
gra-819	30	11	the	the	DET
gra-819	30	12	association	association	NOUN
gra-819	30	13	between	between	ADP
gra-819	30	14	clinical	clinical	ADJ
gra-819	30	15	parameters	parameter	NOUN
gra-819	30	16	of	of	ADP
gra-819	30	17	chronic	chronic	ADJ
gra-819	30	18	urticaria	urticaria	NOUN
gra-819	30	19	and	and	CCONJ
gra-819	30	20	various	various	ADJ
gra-819	30	21	biomarkers	biomarker	NOUN
gra-819	30	22	.	.	PUNCT
gra-819	31	1	methods	method	NOUN
gra-819	31	2	:	:	PUNCT
gra-819	31	3	a	a	DET
gra-819	31	4	retrospective	retrospective	ADJ
gra-819	31	5	cross	cross	ADJ
gra-819	31	6	-	-	ADJ
gra-819	31	7	sectional	sectional	ADJ
gra-819	31	8	data	datum	NOUN
gra-819	31	9	of	of	ADP
gra-819	31	10	134	134	NUM
gra-819	31	11	patients	patient	NOUN
gra-819	31	12	of	of	ADP
gra-819	31	13	chronic	chronic	ADJ
gra-819	31	14	urticaria	urticaria	NOUN
gra-819	31	15	seen	see	VERB
gra-819	31	16	in	in	ADP
gra-819	31	17	allergy	allergy	NOUN
gra-819	31	18	-	-	PUNCT
gra-819	31	19	clinic	clinic	NOUN
gra-819	31	20	,	,	PUNCT
gra-819	31	21	during	during	ADP
gra-819	31	22	recent	recent	ADJ
gra-819	31	23	2	2	NUM
gra-819	31	24	years	year	NOUN
gra-819	31	25	span	span	NOUN
gra-819	31	26	were	be	AUX
gra-819	31	27	collected	collect	VERB
gra-819	31	28	.	.	PUNCT
gra-819	32	1	demographic	demographic	ADJ
gra-819	32	2	details	detail	NOUN
gra-819	32	3	,	,	PUNCT
gra-819	32	4	duration	duration	NOUN
gra-819	32	5	of	of	ADP
gra-819	32	6	the	the	DET
gra-819	32	7	disease	disease	NOUN
gra-819	32	8	,	,	PUNCT
gra-819	32	9	urticaria	urticaria	ADJ
gra-819	32	10	activity	activity	NOUN
gra-819	32	11	score	score	NOUN
gra-819	32	12	(	(	PUNCT
gra-819	32	13	uas	uas	PROPN
gra-819	32	14	)	)	PUNCT
gra-819	32	15	,	,	PUNCT
gra-819	32	16	autologus	autologus	NOUN
gra-819	32	17	serum	serum	NOUN
gra-819	32	18	skin	skin	NOUN
gra-819	32	19	test	test	NOUN
gra-819	32	20	(	(	PUNCT
gra-819	32	21	asst	asst	NOUN
gra-819	32	22	)	)	PUNCT
gra-819	32	23	and	and	CCONJ
gra-819	32	24	various	various	ADJ
gra-819	32	25	autoimmune	autoimmune	NOUN
gra-819	32	26	and	and	CCONJ
gra-819	32	27	inammatory	inammatory	ADJ
gra-819	32	28	laboratory	laboratory	NOUN
gra-819	32	29	parameters	parameter	NOUN
gra-819	32	30	were	be	AUX
gra-819	32	31	included	include	VERB
gra-819	32	32	.	.	PUNCT
gra-819	33	1	results	result	NOUN
gra-819	33	2	:	:	PUNCT
gra-819	33	3	we	we	PRON
gra-819	33	4	found	find	VERB
gra-819	33	5	disease	disease	NOUN
gra-819	33	6	activity	activity	NOUN
gra-819	33	7	(	(	PUNCT
gra-819	33	8	uas	uas	PROPN
gra-819	33	9	)	)	PUNCT
gra-819	33	10	was	be	AUX
gra-819	33	11	signicantly	signicantly	ADV
gra-819	33	12	associated	associate	VERB
gra-819	33	13	with	with	ADP
gra-819	33	14	biomarkers	biomarker	NOUN
gra-819	33	15	,	,	PUNCT
gra-819	33	16	asst	asst	NOUN
gra-819	33	17	(	(	PUNCT
gra-819	33	18	.044	.044	NUM
gra-819	33	19	)	)	PUNCT
gra-819	33	20	,	,	PUNCT
gra-819	33	21	crp	crp	PROPN
gra-819	33	22	(	(	PUNCT
gra-819	33	23	.025	.025	NUM
gra-819	33	24	)	)	PUNCT
gra-819	33	25	and	and	CCONJ
gra-819	33	26	ana	ana	PROPN
gra-819	33	27	(	(	PUNCT
gra-819	33	28	.000	.000	NUM
gra-819	33	29	)	)	PUNCT
gra-819	33	30	.	.	PUNCT
gra-819	34	1	ana	ana	PROPN
gra-819	34	2	positivity	positivity	PROPN
gra-819	34	3	was	be	AUX
gra-819	34	4	signicantly	signicantly	ADV
gra-819	34	5	(	(	PUNCT
gra-819	34	6	.000	.000	NUM
gra-819	34	7	)	)	PUNCT
gra-819	34	8	associated	associate	VERB
gra-819	34	9	with	with	ADP
gra-819	34	10	duration	duration	NOUN
gra-819	34	11	of	of	ADP
gra-819	34	12	the	the	DET
gra-819	34	13	disease	disease	NOUN
gra-819	34	14	.	.	PUNCT
gra-819	35	1	conclusions	conclusion	NOUN
gra-819	35	2	:	:	PUNCT
gra-819	35	3	the	the	DET
gra-819	35	4	present	present	ADJ
gra-819	35	5	study	study	NOUN
gra-819	35	6	found	find	VERB
gra-819	35	7	association	association	NOUN
gra-819	35	8	of	of	ADP
gra-819	35	9	chronic	chronic	ADJ
gra-819	35	10	urticaria	urticaria	NOUN
gra-819	35	11	with	with	ADP
gra-819	35	12	inammatory	inammatory	ADJ
gra-819	35	13	and	and	CCONJ
gra-819	35	14	autoimmune	autoimmune	ADJ
gra-819	35	15	markers	marker	NOUN
gra-819	35	16	;	;	PUNCT
gra-819	35	17	hence	hence	ADV
gra-819	35	18	it	it	PRON
gra-819	35	19	is	be	AUX
gra-819	35	20	important	important	ADJ
gra-819	35	21	to	to	PART
gra-819	35	22	monitor	monitor	VERB
gra-819	35	23	certain	certain	ADJ
gra-819	35	24	laboratory	laboratory	NOUN
gra-819	35	25	testings	testing	NOUN
gra-819	35	26	like	like	ADP
gra-819	35	27	,	,	PUNCT
gra-819	35	28	crp	crp	PROPN
gra-819	35	29	,	,	PUNCT
gra-819	35	30	esr	esr	PROPN
gra-819	35	31	,	,	PUNCT
gra-819	35	32	ana	ana	PROPN
gra-819	35	33	,	,	PUNCT
gra-819	35	34	asst	asst	NOUN
gra-819	35	35	,	,	PUNCT
gra-819	35	36	thyroid	thyroid	VERB
gra-819	35	37	auto	auto	NOUN
gra-819	35	38	antibodies	antibodie	VERB
gra-819	35	39	,	,	PUNCT
gra-819	35	40	ige	ige	PROPN
gra-819	35	41	and	and	CCONJ
gra-819	35	42	routine	routine	ADJ
gra-819	35	43	blood	blood	NOUN
gra-819	35	44	count	count	NOUN
gra-819	35	45	to	to	PART
gra-819	35	46	predict	predict	VERB
gra-819	35	47	the	the	DET
gra-819	35	48	disease	disease	NOUN
gra-819	35	49	duration	duration	NOUN
gra-819	35	50	,	,	PUNCT
gra-819	35	51	severity	severity	NOUN
gra-819	35	52	and	and	CCONJ
gra-819	35	53	to	to	PART
gra-819	35	54	manage	manage	VERB
gra-819	35	55	patients	patient	NOUN
gra-819	35	56	appropriately	appropriately	ADV
gra-819	35	57	.	.	PUNCT
gra-819	36	1	abstract	abstract	ADJ
gra-819	36	2	keywords	keyword	NOUN
gra-819	36	3	:	:	PUNCT
gra-819	36	4	urticaria	urticaria	INTJ
gra-819	36	5	;	;	PUNCT
gra-819	36	6	biomarkers	biomarker	NOUN
gra-819	36	7	;	;	PUNCT
gra-819	36	8	autoimmunity	autoimmunity	NOUN
gra-819	36	9	;	;	PUNCT
gra-819	36	10	inammatory	inammatory	PROPN
gra-819	36	11	dr	dr	PROPN
gra-819	36	12	niharika	niharika	PROPN
gra-819	36	13	dixit	dixit	PROPN
gra-819	36	14	senior	senior	PROPN
gra-819	36	15	resident	resident	NOUN
gra-819	36	16	,	,	PUNCT
gra-819	36	17	department	department	NOUN
gra-819	36	18	of	of	ADP
gra-819	36	19	dermatology	dermatology	NOUN
gra-819	36	20	,	,	PUNCT
gra-819	36	21	abvims	abvim	VERB
gra-819	36	22	,	,	PUNCT
gra-819	36	23	dr	dr	PROPN
gra-819	36	24	rmlh	rmlh	PROPN
gra-819	36	25	,	,	PUNCT
gra-819	36	26	new	new	PROPN
gra-819	36	27	delhi	delhi	PROPN
gra-819	36	28	.	.	PUNCT
gra-819	37	1	dr	dr	PROPN
gra-819	37	2	devika	devika	PROPN
gra-819	37	3	choudhry	choudhry	PROPN
gra-819	37	4	post	post	PROPN
gra-819	37	5	graduate	graduate	PROPN
gra-819	37	6	student	student	NOUN
gra-819	37	7	,	,	PUNCT
gra-819	37	8	department	department	NOUN
gra-819	37	9	of	of	ADP
gra-819	37	10	dermatology	dermatology	NOUN
gra-819	37	11	,	,	PUNCT
gra-819	37	12	abvims	abvim	VERB
gra-819	37	13	,	,	PUNCT
gra-819	37	14	dr	dr	PROPN
gra-819	37	15	rmlh	rmlh	PROPN
gra-819	37	16	,	,	PUNCT
gra-819	37	17	new	new	PROPN
gra-819	37	18	delhi	delhi	PROPN
gra-819	37	19	.	.	PUNCT
gra-819	38	1	volume-8	volume-8	NUM
gra-819	38	2	,	,	PUNCT
gra-819	38	3	issue-11	issue-11	PROPN
gra-819	38	4	,	,	PUNCT
gra-819	38	5	november-2019	november-2019	ADJ
gra-819	38	6	•	•	NOUN
gra-819	38	7	print	print	NOUN
gra-819	38	8	issn	issn	PROPN
gra-819	38	9	no	no	NOUN
gra-819	38	10	.	.	PROPN
gra-819	39	1	2277	2277	NUM
gra-819	39	2	8160	8160	NUM
gra-819	39	3	•	•	NOUN
gra-819	39	4	doi	doi	NOUN
gra-819	39	5	:	:	PUNCT
gra-819	39	6	10.36106	10.36106	NUM
gra-819	39	7	/	/	SYM
gra-819	39	8	gjra	gjra	NOUN
gra-819	39	9	44	44	NUM
gra-819	39	10	x	x	NOUN
gra-819	39	11	gjra	gjra	PROPN
gra-819	39	12	global	global	ADJ
gra-819	39	13	journal	journal	PROPN
gra-819	39	14	for	for	ADP
gra-819	39	15	research	research	NOUN
gra-819	39	16	analysis	analysis	NOUN
gra-819	39	17	dr	dr	PROPN
gra-819	39	18	p.	p.	PROPN
gra-819	39	19	k.	k.	PROPN
gra-819	40	1	sharma	sharma	PROPN
gra-819	40	2	professor	professor	PROPN
gra-819	40	3	,	,	PUNCT
gra-819	40	4	department	department	NOUN
gra-819	40	5	of	of	ADP
gra-819	40	6	dermatology	dermatology	NOUN
gra-819	40	7	,	,	PUNCT
gra-819	40	8	abvims	abvim	VERB
gra-819	40	9	,	,	PUNCT
gra-819	40	10	dr	dr	PROPN
gra-819	40	11	rmlh	rmlh	PROPN
gra-819	40	12	,	,	PUNCT
gra-819	40	13	new	new	ADJ
gra-819	40	14	delhi	delhi	ADJ
gra-819	40	15	26(65	26(65	NUM
gra-819	40	16	%	%	NOUN
gra-819	40	17	)	)	PUNCT
gra-819	40	18	were	be	AUX
gra-819	40	19	female	female	ADJ
gra-819	40	20	and	and	CCONJ
gra-819	40	21	14(35	14(35	NUM
gra-819	40	22	%	%	NOUN
gra-819	40	23	)	)	PUNCT
gra-819	40	24	were	be	AUX
gra-819	40	25	male	male	ADJ
gra-819	40	26	.	.	PUNCT
gra-819	41	1	anti	anti	ADJ
gra-819	41	2	-	-	ADJ
gra-819	41	3	nuclear	nuclear	ADJ
gra-819	41	4	antibodies	antibody	NOUN
gra-819	41	5	and	and	CCONJ
gra-819	41	6	rheumatoid	rheumatoid	NOUN
gra-819	41	7	factors	factor	NOUN
gra-819	41	8	were	be	AUX
gra-819	41	9	found	find	VERB
gra-819	41	10	to	to	PART
gra-819	41	11	be	be	AUX
gra-819	41	12	positive	positive	ADJ
gra-819	41	13	in	in	ADP
gra-819	41	14	20(14.9	20(14.9	NOUN
gra-819	41	15	%	%	NOUN
gra-819	41	16	)	)	PUNCT
gra-819	41	17	of	of	ADP
gra-819	41	18	patients	patient	NOUN
gra-819	41	19	.	.	PUNCT
gra-819	42	1	both	both	DET
gra-819	42	2	ana	ana	PROPN
gra-819	42	3	and	and	CCONJ
gra-819	42	4	rf	rf	PROPN
gra-819	42	5	were	be	AUX
gra-819	42	6	raised	raise	VERB
gra-819	42	7	in	in	ADP
gra-819	42	8	only	only	ADV
gra-819	42	9	3	3	NUM
gra-819	42	10	patients	patient	NOUN
gra-819	42	11	(	(	PUNCT
gra-819	42	12	2.2	2.2	NUM
gra-819	42	13	%	%	NOUN
gra-819	42	14	)	)	PUNCT
gra-819	42	15	.	.	PUNCT
gra-819	43	1	out	out	ADP
gra-819	43	2	of	of	ADP
gra-819	43	3	20	20	NUM
gra-819	43	4	rheumatoid	rheumatoid	NOUN
gra-819	43	5	factor	factor	NOUN
gra-819	43	6	and	and	CCONJ
gra-819	43	7	ana	ana	PROPN
gra-819	43	8	positive	positive	ADJ
gra-819	43	9	patients	patient	NOUN
gra-819	43	10	,	,	PUNCT
gra-819	43	11	12(60	12(60	NUM
gra-819	43	12	%	%	NOUN
gra-819	43	13	)	)	PUNCT
gra-819	43	14	were	be	AUX
gra-819	43	15	female	female	ADJ
gra-819	43	16	and	and	CCONJ
gra-819	43	17	8(40	8(40	NUM
gra-819	43	18	%	%	NOUN
gra-819	43	19	)	)	PUNCT
gra-819	43	20	male	male	NOUN
gra-819	43	21	.	.	PUNCT
gra-819	44	1	ana	ana	PROPN
gra-819	44	2	and	and	CCONJ
gra-819	44	3	asst	asst	NOUN
gra-819	44	4	were	be	AUX
gra-819	44	5	positive	positive	ADJ
gra-819	44	6	in	in	ADP
gra-819	44	7	10	10	NUM
gra-819	44	8	(	(	PUNCT
gra-819	44	9	7.46	7.46	NUM
gra-819	44	10	%	%	NOUN
gra-819	44	11	)	)	PUNCT
gra-819	44	12	cases	case	NOUN
gra-819	44	13	.	.	PUNCT
gra-819	45	1	31(23.5	31(23.5	NUM
gra-819	45	2	%	%	NOUN
gra-819	45	3	)	)	PUNCT
gra-819	45	4	had	have	AUX
gra-819	45	5	risen	rise	VERB
gra-819	45	6	anti	anti	PROPN
gra-819	45	7	thyroid	thyroid	NOUN
gra-819	45	8	antibodies	antibodie	VERB
gra-819	45	9	.	.	PUNCT
gra-819	46	1	serum	serum	PROPN
gra-819	46	2	ige	ige	PROPN
gra-819	46	3	was	be	AUX
gra-819	46	4	signicantly	signicantly	ADV
gra-819	46	5	raised	raise	VERB
gra-819	46	6	in	in	ADP
gra-819	46	7	82(61.2	82(61.2	ADJ
gra-819	46	8	%	%	NOUN
gra-819	46	9	)	)	PUNCT
gra-819	46	10	.	.	PUNCT
gra-819	47	1	laboratory	laboratory	NOUN
gra-819	47	2	inammatory	inammatory	PROPN
gra-819	47	3	markers	marker	NOUN
gra-819	47	4	aso	aso	PROPN
gra-819	47	5	and	and	CCONJ
gra-819	47	6	crp	crp	PROPN
gra-819	47	7	were	be	AUX
gra-819	47	8	positive	positive	ADJ
gra-819	47	9	in	in	ADP
gra-819	47	10	11(8.2	11(8.2	NUM
gra-819	47	11	%	%	NOUN
gra-819	47	12	)	)	PUNCT
gra-819	47	13	and	and	CCONJ
gra-819	47	14	49	49	NUM
gra-819	47	15	(	(	PUNCT
gra-819	47	16	36.6	36.6	NUM
gra-819	47	17	%	%	NOUN
gra-819	47	18	)	)	PUNCT
gra-819	47	19	respectively	respectively	ADV
gra-819	47	20	.	.	PUNCT
gra-819	48	1	routine	routine	ADJ
gra-819	48	2	stool	stool	NOUN
gra-819	48	3	and	and	CCONJ
gra-819	48	4	urine	urine	NOUN
gra-819	48	5	samples	sample	NOUN
gra-819	48	6	were	be	AUX
gra-819	48	7	showed	show	VERB
gra-819	48	8	13(9.7	13(9.7	NUM
gra-819	48	9	%	%	NOUN
gra-819	48	10	)	)	PUNCT
gra-819	48	11	and	and	CCONJ
gra-819	48	12	31(23.1	31(23.1	NUM
gra-819	48	13	%	%	NOUN
gra-819	48	14	)	)	PUNCT
gra-819	48	15	positive	positive	ADJ
gra-819	48	16	for	for	ADP
gra-819	48	17	cyst	cyst	NOUN
gra-819	48	18	of	of	ADP
gra-819	48	19	giardia	giardia	NOUN
gra-819	48	20	and	and	CCONJ
gra-819	48	21	bacteria	bacteria	NOUN
gra-819	48	22	respectively	respectively	ADV
gra-819	48	23	.	.	PUNCT
gra-819	49	1	esr	esr	PROPN
gra-819	49	2	was	be	AUX
gra-819	49	3	raised	raise	VERB
gra-819	49	4	among	among	ADP
gra-819	49	5	32(25	32(25	NUM
gra-819	49	6	%	%	NOUN
gra-819	49	7	)	)	PUNCT
gra-819	49	8	patients	patient	NOUN
gra-819	49	9	as	as	SCONJ
gra-819	49	10	shown	show	VERB
gra-819	49	11	in	in	ADP
gra-819	49	12	table1	table1	PROPN
gra-819	49	13	,	,	PUNCT
gra-819	49	14	2	2	NUM
gra-819	49	15	.	.	X
gra-819	50	1	there	there	PRON
gra-819	50	2	were	be	VERB
gra-819	50	3	no	no	DET
gra-819	50	4	signicant	signicant	ADJ
gra-819	50	5	difference	difference	NOUN
gra-819	50	6	of	of	ADP
gra-819	50	7	all	all	DET
gra-819	50	8	clinical	clinical	ADJ
gra-819	50	9	and	and	CCONJ
gra-819	50	10	lab	lab	NOUN
gra-819	50	11	parameters	parameter	NOUN
gra-819	50	12	in	in	ADP
gra-819	50	13	both	both	DET
gra-819	50	14	sexes	sex	NOUN
gra-819	50	15	except	except	SCONJ
gra-819	50	16	esr	esr	PROPN
gra-819	50	17	in	in	ADP
gra-819	50	18	female	female	ADJ
gra-819	50	19	(	(	PUNCT
gra-819	50	20	p=.007	p=.007	ADJ
gra-819	50	21	)	)	PUNCT
gra-819	50	22	,	,	PUNCT
gra-819	50	23	comparison	comparison	NOUN
gra-819	50	24	to	to	ADP
gra-819	50	25	male	male	NOUN
gra-819	50	26	.	.	PUNCT
gra-819	51	1	we	we	PRON
gra-819	51	2	found	find	VERB
gra-819	51	3	positive	positive	ADJ
gra-819	51	4	association	association	NOUN
gra-819	51	5	of	of	ADP
gra-819	51	6	age	age	NOUN
gra-819	51	7	with	with	ADP
gra-819	51	8	duration	duration	NOUN
gra-819	51	9	(	(	PUNCT
gra-819	51	10	p=.000	p=.000	PROPN
gra-819	51	11	)	)	PUNCT
gra-819	51	12	,	,	PUNCT
gra-819	51	13	serum	serum	PROPN
gra-819	51	14	ige	ige	PROPN
gra-819	51	15	(	(	PUNCT
gra-819	51	16	p=.025	p=.025	ADJ
gra-819	51	17	)	)	PUNCT
gra-819	51	18	and	and	CCONJ
gra-819	51	19	esr	esr	PROPN
gra-819	51	20	(	(	PUNCT
gra-819	51	21	.044	.044	NUM
gra-819	51	22	)	)	PUNCT
gra-819	51	23	.	.	PUNCT
gra-819	52	1	the	the	DET
gra-819	52	2	study	study	NOUN
gra-819	52	3	showed	show	VERB
gra-819	52	4	positive	positive	ADJ
gra-819	52	5	association	association	NOUN
gra-819	52	6	of	of	ADP
gra-819	52	7	crp	crp	PROPN
gra-819	52	8	with	with	ADP
gra-819	52	9	uas	uas	PROPN
gra-819	52	10	(	(	PUNCT
gra-819	52	11	.025	.025	NUM
gra-819	52	12	)	)	PUNCT
gra-819	52	13	and	and	CCONJ
gra-819	52	14	raised	raise	VERB
gra-819	52	15	count	count	NOUN
gra-819	52	16	of	of	ADP
gra-819	52	17	total	total	ADJ
gra-819	52	18	leucocytes	leucocyte	NOUN
gra-819	52	19	(	(	PUNCT
gra-819	52	20	.025	.025	NUM
gra-819	52	21	)	)	PUNCT
gra-819	52	22	.	.	PUNCT
gra-819	53	1	absolute	absolute	ADJ
gra-819	53	2	eosinophil	eosinophil	ADJ
gra-819	53	3	counts	count	NOUN
gra-819	53	4	(	(	PUNCT
gra-819	53	5	aec	aec	PROPN
gra-819	53	6	)	)	PUNCT
gra-819	53	7	was	be	AUX
gra-819	53	8	associated	associate	VERB
gra-819	53	9	with	with	ADP
gra-819	53	10	raised	raise	VERB
gra-819	53	11	tlc	tlc	NOUN
gra-819	53	12	and	and	CCONJ
gra-819	53	13	uas	uas	NOUN
gra-819	53	14	with	with	ADP
gra-819	53	15	statistical	statistical	ADJ
gra-819	53	16	signicant	signicant	ADJ
gra-819	53	17	p	p	NOUN
gra-819	53	18	value	value	NOUN
gra-819	53	19	of	of	ADP
gra-819	53	20	.025	.025	NUM
gra-819	53	21	and	and	CCONJ
gra-819	53	22	.043	.043	NUM
gra-819	53	23	respectively	respectively	ADV
gra-819	53	24	.	.	PUNCT
gra-819	54	1	raised	raise	VERB
gra-819	54	2	esr	esr	PROPN
gra-819	54	3	associated	associate	VERB
gra-819	54	4	with	with	ADP
gra-819	54	5	ana	ana	PROPN
gra-819	54	6	,	,	PUNCT
gra-819	54	7	anti	anti	ADJ
gra-819	54	8	-	-	ADJ
gra-819	54	9	tpo	tpo	NOUN
gra-819	54	10	and	and	CCONJ
gra-819	54	11	positive	positive	ADJ
gra-819	54	12	stool	stool	NOUN
gra-819	54	13	test	test	NOUN
gra-819	54	14	for	for	ADP
gra-819	54	15	giardiasis	giardiasis	NOUN
gra-819	54	16	with	with	ADP
gra-819	54	17	signicant	signicant	PROPN
gra-819	54	18	p	p	PROPN
gra-819	54	19	value.026	value.026	PROPN
gra-819	54	20	,	,	PUNCT
gra-819	54	21	.024	.024	NUM
gra-819	54	22	and	and	CCONJ
gra-819	54	23	.027	.027	NUM
gra-819	54	24	respectively	respectively	ADV
gra-819	54	25	.	.	PUNCT
gra-819	55	1	all	all	DET
gra-819	55	2	cu	cu	PROPN
gra-819	55	3	patients	patient	NOUN
gra-819	55	4	with	with	ADP
gra-819	55	5	rf	rf	PRON
gra-819	55	6	positive	positive	ADJ
gra-819	55	7	were	be	AUX
gra-819	55	8	associated	associate	VERB
gra-819	55	9	with	with	ADP
gra-819	55	10	raised	raise	VERB
gra-819	55	11	serum	serum	PROPN
gra-819	55	12	ige	ige	PROPN
gra-819	55	13	(	(	PUNCT
gra-819	55	14	.020	.020	NUM
gra-819	55	15	)	)	PUNCT
gra-819	55	16	ana	ana	PROPN
gra-819	55	17	positivity	positivity	NOUN
gra-819	55	18	was	be	AUX
gra-819	55	19	signicantly	signicantly	ADV
gra-819	55	20	(	(	PUNCT
gra-819	55	21	.000	.000	NUM
gra-819	55	22	)	)	PUNCT
gra-819	55	23	associated	associate	VERB
gra-819	55	24	with	with	ADP
gra-819	55	25	duration	duration	NOUN
gra-819	55	26	of	of	ADP
gra-819	55	27	the	the	DET
gra-819	55	28	disease	disease	NOUN
gra-819	55	29	,	,	PUNCT
gra-819	55	30	raised	raise	VERB
gra-819	55	31	esr	esr	PROPN
gra-819	55	32	(	(	PUNCT
gra-819	55	33	0.026	0.026	NUM
gra-819	55	34	)	)	PUNCT
gra-819	55	35	and	and	CCONJ
gra-819	55	36	uas	uas	PROPN
gra-819	55	37	(	(	PUNCT
gra-819	55	38	0.000	0.000	NUM
gra-819	55	39	)	)	PUNCT
gra-819	55	40	.	.	PUNCT
gra-819	56	1	positive	positive	ADJ
gra-819	56	2	result	result	NOUN
gra-819	56	3	of	of	ADP
gra-819	56	4	asst	asst	NOUN
gra-819	56	5	was	be	AUX
gra-819	56	6	signicantly	signicantly	ADV
gra-819	56	7	correlated	correlate	VERB
gra-819	56	8	with	with	ADP
gra-819	56	9	uas	uas	PROPN
gra-819	56	10	(	(	PUNCT
gra-819	56	11	.044	.044	NUM
gra-819	56	12	)	)	PUNCT
gra-819	56	13	as	as	SCONJ
gra-819	56	14	shown	show	VERB
gra-819	56	15	in	in	ADP
gra-819	56	16	table	table	NOUN
gra-819	56	17	3	3	NUM
gra-819	56	18	.	.	X
gra-819	56	19	angioedema	angioedema	NOUN
gra-819	56	20	was	be	AUX
gra-819	56	21	found	find	VERB
gra-819	56	22	in	in	ADP
gra-819	56	23	only	only	ADV
gra-819	56	24	4(3	4(3	NUM
gra-819	56	25	%	%	NOUN
gra-819	56	26	)	)	PUNCT
gra-819	56	27	person	person	NOUN
gra-819	56	28	.	.	PUNCT
gra-819	57	1	discussion	discussion	NOUN
gra-819	57	2	the	the	DET
gra-819	57	3	present	present	ADJ
gra-819	57	4	study	study	NOUN
gra-819	57	5	has	have	AUX
gra-819	57	6	shown	show	VERB
gra-819	57	7	68.7	68.7	NUM
gra-819	57	8	%	%	NOUN
gra-819	57	9	female	female	ADJ
gra-819	57	10	preponderance	preponderance	NOUN
gra-819	57	11	similar	similar	ADJ
gra-819	57	12	to	to	ADP
gra-819	57	13	previous	previous	ADJ
gra-819	57	14	studies	study	NOUN
gra-819	57	15	(	(	PUNCT
gra-819	57	16	11	11	NUM
gra-819	57	17	)	)	PUNCT
gra-819	57	18	.	.	PUNCT
gra-819	58	1	the	the	DET
gra-819	58	2	mean	mean	ADJ
gra-819	58	3	age	age	NOUN
gra-819	58	4	of	of	ADP
gra-819	58	5	the	the	DET
gra-819	58	6	patients	patient	NOUN
gra-819	58	7	were	be	AUX
gra-819	58	8	35.45	35.45	NUM
gra-819	58	9	years	year	NOUN
gra-819	58	10	which	which	PRON
gra-819	58	11	was	be	AUX
gra-819	58	12	comparable	comparable	ADJ
gra-819	58	13	to	to	ADP
gra-819	58	14	the	the	DET
gra-819	58	15	study	study	NOUN
gra-819	58	16	done	do	VERB
gra-819	58	17	by	by	ADP
gra-819	58	18	george	george	PROPN
gra-819	58	19	et	et	PROPN
gra-819	58	20	al	al	PROPN
gra-819	58	21	(	(	PUNCT
gra-819	58	22	13).average	13).average	NUM
gra-819	58	23	duration	duration	NOUN
gra-819	58	24	of	of	ADP
gra-819	58	25	chronic	chronic	ADJ
gra-819	58	26	urticaria	urticaria	NOUN
gra-819	58	27	was	be	AUX
gra-819	58	28	38	38	NUM
gra-819	58	29	months	month	NOUN
gra-819	58	30	and	and	CCONJ
gra-819	58	31	cu	cu	PROPN
gra-819	58	32	patients	patient	NOUN
gra-819	58	33	with	with	ADP
gra-819	58	34	ana	ana	PROPN
gra-819	58	35	positivity	positivity	NOUN
gra-819	58	36	had	have	VERB
gra-819	58	37	prolonged	prolong	VERB
gra-819	58	38	duration	duration	NOUN
gra-819	58	39	(	(	PUNCT
gra-819	58	40	11	11	NUM
gra-819	58	41	)	)	PUNCT
gra-819	58	42	.	.	PUNCT
gra-819	59	1	we	we	PRON
gra-819	59	2	found	find	VERB
gra-819	59	3	,	,	PUNCT
gra-819	59	4	elderly	elderly	ADJ
gra-819	59	5	patients	patient	NOUN
gra-819	59	6	had	have	VERB
gra-819	59	7	prolonged	prolong	VERB
gra-819	59	8	disease	disease	NOUN
gra-819	59	9	-	-	PUNCT
gra-819	59	10	duration	duration	NOUN
gra-819	59	11	(	(	PUNCT
gra-819	59	12	.000	.000	NUM
gra-819	59	13	)	)	PUNCT
gra-819	59	14	with	with	ADP
gra-819	59	15	raised	raise	VERB
gra-819	59	16	value	value	NOUN
gra-819	59	17	of	of	ADP
gra-819	59	18	esr	esr	PROPN
gra-819	59	19	(	(	PUNCT
gra-819	59	20	.040	.040	NUM
gra-819	59	21	)	)	PUNCT
gra-819	59	22	and	and	CCONJ
gra-819	59	23	serum	serum	PROPN
gra-819	59	24	ige	ige	PROPN
gra-819	59	25	(	(	PUNCT
gra-819	59	26	.025	.025	NUM
gra-819	59	27	)	)	PUNCT
gra-819	59	28	.	.	PUNCT
gra-819	60	1	although	although	SCONJ
gra-819	60	2	measuring	measure	VERB
gra-819	60	3	ana	ana	PROPN
gra-819	60	4	serves	serve	VERB
gra-819	60	5	as	as	ADP
gra-819	60	6	a	a	DET
gra-819	60	7	nonspecic	nonspecic	ADJ
gra-819	60	8	marker	marker	NOUN
gra-819	60	9	of	of	ADP
gra-819	60	10	systemic	systemic	ADJ
gra-819	60	11	autoimmunity	autoimmunity	NOUN
gra-819	60	12	,	,	PUNCT
gra-819	60	13	its	its	PRON
gra-819	60	14	relationship	relationship	NOUN
gra-819	60	15	with	with	ADP
gra-819	60	16	cu	cu	PROPN
gra-819	60	17	is	be	AUX
gra-819	60	18	poorly	poorly	ADV
gra-819	60	19	understood	understand	VERB
gra-819	60	20	.	.	PUNCT
gra-819	61	1	nonetheless	nonetheless	ADV
gra-819	61	2	,	,	PUNCT
gra-819	61	3	positive	positive	ADJ
gra-819	61	4	ana	ana	PROPN
gra-819	61	5	has	have	AUX
gra-819	61	6	been	be	AUX
gra-819	61	7	found	find	VERB
gra-819	61	8	to	to	PART
gra-819	61	9	have	have	VERB
gra-819	61	10	some	some	DET
gra-819	61	11	correlation	correlation	NOUN
gra-819	61	12	with	with	ADP
gra-819	61	13	ciu	ciu	ADJ
gra-819	61	14	severity	severity	NOUN
gra-819	61	15	and	and	CCONJ
gra-819	61	16	was	be	AUX
gra-819	61	17	strongly	strongly	ADV
gra-819	61	18	associated	associate	VERB
gra-819	61	19	with	with	ADP
gra-819	61	20	refractoriness	refractoriness	NOUN
gra-819	61	21	to	to	ADP
gra-819	61	22	antihistamines	antihistamine	NOUN
gra-819	61	23	(	(	PUNCT
gra-819	61	24	14	14	NUM
gra-819	61	25	)	)	PUNCT
gra-819	61	26	.	.	PUNCT
gra-819	62	1	was	be	AUX
gra-819	62	2	associated	associate	VERB
gra-819	62	3	whereas	whereas	SCONJ
gra-819	62	4	in	in	ADP
gra-819	62	5	other	other	ADJ
gra-819	62	6	study	study	NOUN
gra-819	62	7	cu	cu	PROPN
gra-819	62	8	duration	duration	NOUN
gra-819	62	9	clinical	clinical	ADJ
gra-819	62	10	parameters	parameter	NOUN
gra-819	62	11	such	such	ADJ
gra-819	62	12	as	as	ADP
gra-819	62	13	severity	severity	NOUN
gra-819	62	14	and	and	CCONJ
gra-819	62	15	angioedema	angioedema	VERB
gra-819	62	16	,	,	PUNCT
gra-819	62	17	and	and	CCONJ
gra-819	62	18	presence	presence	NOUN
gra-819	62	19	of	of	ADP
gra-819	62	20	both	both	CCONJ
gra-819	62	21	autologous	autologous	ADJ
gra-819	62	22	serum	serum	NOUN
gra-819	62	23	test	test	NOUN
gra-819	62	24	and	and	CCONJ
gra-819	62	25	anti	anti	ADJ
gra-819	62	26	-	-	ADJ
gra-819	62	27	thyroid	thyroid	ADJ
gra-819	62	28	antibodies	antibody	NOUN
gra-819	62	29	(	(	PUNCT
gra-819	62	30	15	15	NUM
gra-819	62	31	)	)	PUNCT
gra-819	62	32	.	.	PUNCT
gra-819	63	1	in	in	ADP
gra-819	63	2	our	our	PRON
gra-819	63	3	study	study	NOUN
gra-819	63	4	disease	disease	NOUN
gra-819	63	5	duration	duration	NOUN
gra-819	63	6	was	be	AUX
gra-819	63	7	associated	associate	VERB
gra-819	63	8	with	with	ADP
gra-819	63	9	age	age	NOUN
gra-819	63	10	,	,	PUNCT
gra-819	63	11	crp	crp	PROPN
gra-819	63	12	,	,	PUNCT
gra-819	63	13	ana	ana	PROPN
gra-819	63	14	and	and	CCONJ
gra-819	63	15	asst	asst	NOUN
gra-819	63	16	positivity	positivity	NOUN
gra-819	63	17	.	.	PUNCT
gra-819	64	1	asst	asst	PROPN
gra-819	64	2	was	be	AUX
gra-819	64	3	found	find	VERB
gra-819	64	4	to	to	PART
gra-819	64	5	be	be	AUX
gra-819	64	6	positive	positive	ADJ
gra-819	64	7	in	in	ADP
gra-819	64	8	40	40	NUM
gra-819	64	9	patients	patient	NOUN
gra-819	64	10	(	(	PUNCT
gra-819	64	11	29.9	29.9	NUM
gra-819	64	12	%	%	NOUN
gra-819	64	13	)	)	PUNCT
gra-819	64	14	,	,	PUNCT
gra-819	64	15	these	these	PRON
gra-819	64	16	were	be	AUX
gra-819	64	17	associated	associate	VERB
gra-819	64	18	with	with	ADP
gra-819	64	19	moderate	moderate	ADJ
gra-819	64	20	to	to	ADP
gra-819	64	21	severe	severe	ADJ
gra-819	64	22	grade	grade	NOUN
gra-819	64	23	of	of	ADP
gra-819	64	24	urticaria	urticaria	NOUN
gra-819	64	25	(	(	PUNCT
gra-819	64	26	uas	uas	PROPN
gra-819	64	27	)	)	PUNCT
gra-819	64	28	.	.	PUNCT
gra-819	65	1	some	some	DET
gra-819	65	2	studies	study	NOUN
gra-819	65	3	also	also	ADV
gra-819	65	4	showed	show	VERB
gra-819	65	5	severe	severe	ADJ
gra-819	65	6	clinical	clinical	ADJ
gra-819	65	7	features	feature	NOUN
gra-819	65	8	in	in	ADP
gra-819	65	9	asst	asst	NOUN
gra-819	65	10	positive	positive	ADJ
gra-819	65	11	cu	cu	PROPN
gra-819	65	12	than	than	ADP
gra-819	65	13	asst	asst	NOUN
gra-819	65	14	negative(16	negative(16	NOUN
gra-819	65	15	)	)	PUNCT
gra-819	65	16	,	,	PUNCT
gra-819	65	17	in	in	ADP
gra-819	65	18	contrast	contrast	NOUN
gra-819	65	19	to	to	ADP
gra-819	65	20	the	the	DET
gra-819	65	21	other	other	ADJ
gra-819	65	22	study	study	NOUN
gra-819	65	23	which	which	PRON
gra-819	65	24	did	do	AUX
gra-819	65	25	not	not	PART
gra-819	65	26	found	find	VERB
gra-819	65	27	such	such	ADJ
gra-819	65	28	association	association	NOUN
gra-819	65	29	(	(	PUNCT
gra-819	65	30	17	17	NUM
gra-819	65	31	)	)	PUNCT
gra-819	65	32	.	.	PUNCT
gra-819	66	1	similar	similar	ADJ
gra-819	66	2	to	to	ADP
gra-819	66	3	most	most	ADJ
gra-819	66	4	of	of	ADP
gra-819	66	5	the	the	DET
gra-819	66	6	previous	previous	ADJ
gra-819	66	7	studies	study	NOUN
gra-819	66	8	,	,	PUNCT
gra-819	66	9	our	our	PRON
gra-819	66	10	study	study	NOUN
gra-819	66	11	was	be	AUX
gra-819	66	12	found	find	VERB
gra-819	66	13	positive	positive	ADJ
gra-819	66	14	correlation	correlation	NOUN
gra-819	66	15	between	between	ADP
gra-819	66	16	crp	crp	PROPN
gra-819	66	17	and	and	CCONJ
gra-819	66	18	severity	severity	NOUN
gra-819	66	19	of	of	ADP
gra-819	66	20	urticaria	urticaria	NOUN
gra-819	66	21	(	(	PUNCT
gra-819	66	22	17	17	NUM
gra-819	66	23	,	,	PUNCT
gra-819	66	24	18).this	18).this	NUM
gra-819	66	25	indicates	indicate	VERB
gra-819	66	26	that	that	SCONJ
gra-819	66	27	crp	crp	PROPN
gra-819	66	28	levels	level	NOUN
gra-819	66	29	reect	reect	ADJ
gra-819	66	30	activity	activity	NOUN
gra-819	66	31	of	of	ADP
gra-819	66	32	disease	disease	NOUN
gra-819	66	33	and	and	CCONJ
gra-819	66	34	it	it	PRON
gra-819	66	35	may	may	AUX
gra-819	66	36	serve	serve	VERB
gra-819	66	37	as	as	ADP
gra-819	66	38	a	a	DET
gra-819	66	39	biomarker	biomarker	NOUN
gra-819	66	40	to	to	PART
gra-819	66	41	monitor	monitor	VERB
gra-819	66	42	csu	csu	PROPN
gra-819	66	43	patients	patient	NOUN
gra-819	66	44	.	.	PUNCT
gra-819	67	1	crp	crp	PROPN
gra-819	67	2	positive	positive	ADJ
gra-819	67	3	individual	individual	NOUN
gra-819	67	4	also	also	ADV
gra-819	67	5	had	have	AUX
gra-819	67	6	raised	raise	VERB
gra-819	67	7	total	total	ADJ
gra-819	67	8	leukocytes	leukocyte	NOUN
gra-819	67	9	counts	count	NOUN
gra-819	67	10	(	(	PUNCT
gra-819	67	11	tlc	tlc	NOUN
gra-819	67	12	)	)	PUNCT
gra-819	67	13	.	.	PUNCT
gra-819	68	1	we	we	PRON
gra-819	68	2	found	find	VERB
gra-819	68	3	association	association	NOUN
gra-819	68	4	of	of	ADP
gra-819	68	5	raised	raise	VERB
gra-819	68	6	serum	serum	NOUN
gra-819	68	7	ige	ige	PROPN
gra-819	68	8	with	with	ADP
gra-819	68	9	positive	positive	ADJ
gra-819	68	10	rf	rf	NOUN
gra-819	68	11	.	.	PUNCT
gra-819	69	1	rf	rf	PROPN
gra-819	69	2	were	be	AUX
gra-819	69	3	positive	positive	ADJ
gra-819	69	4	in	in	ADP
gra-819	69	5	20(14.9	20(14.9	NOUN
gra-819	69	6	%	%	NOUN
gra-819	69	7	)	)	PUNCT
gra-819	70	1	patients	patient	NOUN
gra-819	70	2	all	all	PRON
gra-819	70	3	had	have	AUX
gra-819	70	4	raised	raise	VERB
gra-819	70	5	serum	serum	NOUN
gra-819	70	6	ige	ige	PROPN
gra-819	70	7	level	level	NOUN
gra-819	70	8	.	.	PUNCT
gra-819	71	1	earlier	early	ADJ
gra-819	71	2	studies	study	NOUN
gra-819	71	3	also	also	ADV
gra-819	71	4	found	find	VERB
gra-819	71	5	high	high	ADJ
gra-819	71	6	titres	titre	NOUN
gra-819	71	7	of	of	ADP
gra-819	71	8	ige	ige	PROPN
gra-819	71	9	in	in	ADP
gra-819	71	10	serum	serum	NOUN
gra-819	71	11	of	of	ADP
gra-819	71	12	rheumatoid	rheumatoid	NOUN
gra-819	71	13	arthritis	arthritis	NOUN
gra-819	71	14	(	(	PUNCT
gra-819	71	15	ra	ra	NOUN
gra-819	71	16	)	)	PUNCT
gra-819	71	17	(	(	PUNCT
gra-819	71	18	19	19	NUM
gra-819	71	19	,	,	PUNCT
gra-819	71	20	20)patients	20)patient	NOUN
gra-819	71	21	but	but	CCONJ
gra-819	71	22	no	no	DET
gra-819	71	23	increased	increase	VERB
gra-819	71	24	prevalence	prevalence	NOUN
gra-819	71	25	of	of	ADP
gra-819	71	26	atopy	atopy	NOUN
gra-819	71	27	(	(	PUNCT
gra-819	71	28	21	21	NUM
gra-819	71	29	,	,	PUNCT
gra-819	71	30	22	22	NUM
gra-819	71	31	)	)	PUNCT
gra-819	71	32	rather	rather	ADV
gra-819	71	33	decreased	decrease	VERB
gra-819	71	34	prevalence	prevalence	NOUN
gra-819	71	35	(	(	PUNCT
gra-819	71	36	23	23	NUM
gra-819	71	37	)	)	PUNCT
gra-819	71	38	.	.	PUNCT
gra-819	72	1	de	de	PROPN
gra-819	72	2	clerck	clerck	AUX
gra-819	72	3	et	et	PROPN
gra-819	72	4	al	al	PROPN
gra-819	72	5	.	.	PROPN
gra-819	72	6	found	find	VERB
gra-819	72	7	elevated	elevated	ADJ
gra-819	72	8	ige	ige	PROPN
gra-819	72	9	levels	level	NOUN
gra-819	72	10	and	and	CCONJ
gra-819	72	11	ige	ige	PROPN
gra-819	72	12	circulating	circulating	ADJ
gra-819	72	13	immune	immune	ADJ
gra-819	72	14	complex	complex	NOUN
gra-819	72	15	in	in	ADP
gra-819	72	16	ra	ra	PROPN
gra-819	72	17	patients	patient	NOUN
gra-819	72	18	more	more	ADV
gra-819	72	19	frequently	frequently	ADV
gra-819	72	20	than	than	ADP
gra-819	72	21	in	in	ADP
gra-819	72	22	patients	patient	NOUN
gra-819	72	23	with	with	ADP
gra-819	72	24	allergic	allergic	ADJ
gra-819	72	25	asthma	asthma	NOUN
gra-819	72	26	and	and	CCONJ
gra-819	72	27	good	good	ADJ
gra-819	72	28	correlation	correlation	NOUN
gra-819	72	29	between	between	ADP
gra-819	72	30	skin	skin	NOUN
gra-819	72	31	ige	ige	PROPN
gra-819	72	32	deposition	deposition	NOUN
gra-819	72	33	and	and	CCONJ
gra-819	72	34	extra	extra	ADJ
gra-819	72	35	articular	articular	ADJ
gra-819	72	36	manifestations	manifestation	NOUN
gra-819	72	37	of	of	ADP
gra-819	72	38	ra	ra	PROPN
gra-819	72	39	.	.	PUNCT
gra-819	73	1	in	in	ADP
gra-819	73	2	our	our	PRON
gra-819	73	3	studies	study	NOUN
gra-819	73	4	we	we	PRON
gra-819	73	5	did	do	VERB
gra-819	73	6	not	not	PART
gra-819	73	7	nd	nd	ADV
gra-819	73	8	any	any	DET
gra-819	73	9	clinical	clinical	ADJ
gra-819	73	10	severity	severity	NOUN
gra-819	73	11	in	in	ADP
gra-819	73	12	rf	rf	PRON
gra-819	73	13	positive	positive	ADJ
gra-819	73	14	cu	cu	NOUN
gra-819	73	15	patients	patient	NOUN
gra-819	73	16	with	with	ADP
gra-819	73	17	raised	raise	VERB
gra-819	73	18	serum	serum	PROPN
gra-819	73	19	ige	ige	PROPN
gra-819	73	20	.	.	PUNCT
gra-819	74	1	we	we	PRON
gra-819	74	2	also	also	ADV
gra-819	74	3	did	do	AUX
gra-819	74	4	not	not	PART
gra-819	74	5	found	find	VERB
gra-819	74	6	any	any	DET
gra-819	74	7	correlation	correlation	NOUN
gra-819	74	8	of	of	ADP
gra-819	74	9	thyroid	thyroid	NOUN
gra-819	74	10	autoantibodies	autoantibody	NOUN
gra-819	74	11	to	to	ADP
gra-819	74	12	sex	sex	NOUN
gra-819	74	13	,	,	PUNCT
gra-819	74	14	duration	duration	NOUN
gra-819	74	15	,	,	PUNCT
gra-819	74	16	severity	severity	NOUN
gra-819	74	17	,	,	PUNCT
gra-819	74	18	asst	asst	NOUN
gra-819	74	19	,	,	PUNCT
gra-819	74	20	ana	ana	PROPN
gra-819	74	21	positivity	positivity	NOUN
gra-819	74	22	in	in	ADP
gra-819	74	23	cu	cu	PROPN
gra-819	74	24	.	.	PROPN
gra-819	75	1	elevated	elevated	PROPN
gra-819	75	2	esr	esr	PROPN
gra-819	75	3	was	be	AUX
gra-819	75	4	seen	see	VERB
gra-819	75	5	in	in	ADP
gra-819	75	6	thyroid	thyroid	NOUN
gra-819	75	7	auto	auto	NOUN
gra-819	75	8	-	-	PUNCT
gra-819	75	9	antibodies	antibodie	VERB
gra-819	75	10	positive	positive	ADJ
gra-819	75	11	patients	patient	NOUN
gra-819	75	12	(	(	PUNCT
gra-819	75	13	p=.024	p=.024	NOUN
gra-819	75	14	)	)	PUNCT
gra-819	75	15	similar	similar	ADJ
gra-819	75	16	to	to	PART
gra-819	75	17	result	result	VERB
gra-819	75	18	found	find	VERB
gra-819	75	19	in	in	ADP
gra-819	75	20	other	other	ADJ
gra-819	75	21	study	study	NOUN
gra-819	75	22	(	(	PUNCT
gra-819	75	23	24	24	NUM
gra-819	75	24	)	)	PUNCT
gra-819	75	25	,	,	PUNCT
gra-819	75	26	ana	ana	PROPN
gra-819	75	27	positive	positive	ADJ
gra-819	75	28	,	,	PUNCT
gra-819	75	29	female	female	ADJ
gra-819	75	30	and	and	CCONJ
gra-819	75	31	elderly	elderly	ADJ
gra-819	75	32	individuals	individual	NOUN
gra-819	75	33	and	and	CCONJ
gra-819	75	34	patients	patient	NOUN
gra-819	75	35	associated	associate	VERB
gra-819	75	36	with	with	ADP
gra-819	75	37	positive	positive	ADJ
gra-819	75	38	stool	stool	NOUN
gra-819	75	39	test	test	NOUN
gra-819	75	40	for	for	ADP
gra-819	75	41	ova	ova	NOUN
gra-819	75	42	and	and	CCONJ
gra-819	75	43	cyst	cyst	NOUN
gra-819	75	44	.	.	PUNCT
gra-819	76	1	raised	raise	VERB
gra-819	76	2	aec	aec	PROPN
gra-819	76	3	were	be	AUX
gra-819	76	4	found	find	VERB
gra-819	76	5	to	to	PART
gra-819	76	6	be	be	AUX
gra-819	76	7	associated	associate	VERB
gra-819	76	8	with	with	ADP
gra-819	76	9	raised	raise	VERB
gra-819	76	10	tlc	tlc	NOUN
gra-819	76	11	and	and	CCONJ
gra-819	76	12	cu	cu	PROPN
gra-819	76	13	severity	severity	NOUN
gra-819	76	14	.	.	PUNCT
gra-819	77	1	conclusions	conclusion	NOUN
gra-819	77	2	in	in	ADP
gra-819	77	3	our	our	PRON
gra-819	77	4	study	study	NOUN
gra-819	77	5	we	we	PRON
gra-819	77	6	found	find	VERB
gra-819	77	7	,	,	PUNCT
gra-819	77	8	chronic	chronic	ADJ
gra-819	77	9	urticaria	urticaria	NOUN
gra-819	77	10	was	be	AUX
gra-819	77	11	seen	see	VERB
gra-819	77	12	more	more	ADV
gra-819	77	13	commonly	commonly	ADV
gra-819	77	14	in	in	ADP
gra-819	77	15	female	female	NOUN
gra-819	77	16	.	.	PUNCT
gra-819	78	1	disease	disease	NOUN
gra-819	78	2	duration	duration	NOUN
gra-819	78	3	was	be	AUX
gra-819	78	4	prolonged	prolong	VERB
gra-819	78	5	in	in	ADP
gra-819	78	6	elderly	elderly	ADJ
gra-819	78	7	and	and	CCONJ
gra-819	78	8	patients	patient	NOUN
gra-819	78	9	with	with	ADP
gra-819	78	10	autoimmunity	autoimmunity	NOUN
gra-819	78	11	.	.	PUNCT
gra-819	79	1	disease	disease	NOUN
gra-819	79	2	severity	severity	NOUN
gra-819	79	3	was	be	AUX
gra-819	79	4	found	find	VERB
gra-819	79	5	to	to	PART
gra-819	79	6	be	be	AUX
gra-819	79	7	associated	associate	VERB
gra-819	79	8	with	with	ADP
gra-819	79	9	inammatory	inammatory	ADJ
gra-819	79	10	marker	marker	NOUN
gra-819	79	11	-	-	PUNCT
gra-819	79	12	crp	crp	NOUN
gra-819	79	13	positivity	positivity	NOUN
gra-819	79	14	,	,	PUNCT
gra-819	79	15	peripheral	peripheral	ADJ
gra-819	79	16	eosinophilia	eosinophilia	PROPN
gra-819	79	17	and	and	CCONJ
gra-819	79	18	ana	ana	PROPN
gra-819	79	19	,	,	PUNCT
gra-819	79	20	asst	asst	NOUN
gra-819	79	21	positivity	positivity	NOUN
gra-819	79	22	.	.	PUNCT
gra-819	80	1	hence	hence	ADV
gra-819	80	2	,	,	PUNCT
gra-819	80	3	it	it	PRON
gra-819	80	4	is	be	AUX
gra-819	80	5	important	important	ADJ
gra-819	80	6	to	to	PART
gra-819	80	7	monitor	monitor	VERB
gra-819	80	8	certain	certain	ADJ
gra-819	80	9	laboratory	laboratory	NOUN
gra-819	80	10	testings	testing	NOUN
gra-819	80	11	like	like	ADP
gra-819	80	12	,	,	PUNCT
gra-819	80	13	crp	crp	PROPN
gra-819	80	14	,	,	PUNCT
gra-819	80	15	esr	esr	PROPN
gra-819	80	16	,	,	PUNCT
gra-819	80	17	ana	ana	PROPN
gra-819	80	18	,	,	PUNCT
gra-819	80	19	asst	asst	NOUN
gra-819	80	20	,	,	PUNCT
gra-819	80	21	thyroid	thyroid	VERB
gra-819	80	22	auto	auto	NOUN
gra-819	80	23	antibodies	antibodie	VERB
gra-819	80	24	,	,	PUNCT
gra-819	80	25	ige	ige	PROPN
gra-819	80	26	and	and	CCONJ
gra-819	80	27	routine	routine	ADJ
gra-819	80	28	blood	blood	NOUN
gra-819	80	29	count	count	NOUN
gra-819	80	30	to	to	PART
gra-819	80	31	predict	predict	VERB
gra-819	80	32	the	the	DET
gra-819	80	33	disease	disease	NOUN
gra-819	80	34	duration	duration	NOUN
gra-819	80	35	and	and	CCONJ
gra-819	80	36	severity	severity	NOUN
gra-819	80	37	and	and	CCONJ
gra-819	80	38	to	to	PART
gra-819	80	39	manage	manage	VERB
gra-819	80	40	patients	patient	NOUN
gra-819	80	41	appropriately	appropriately	ADV
gra-819	80	42	.	.	PUNCT
gra-819	81	1	the	the	DET
gra-819	81	2	limitation	limitation	NOUN
gra-819	81	3	was	be	AUX
gra-819	81	4	that	that	SCONJ
gra-819	81	5	we	we	PRON
gra-819	81	6	have	have	AUX
gra-819	81	7	not	not	PART
gra-819	81	8	covered	cover	VERB
gra-819	81	9	the	the	DET
gra-819	81	10	therapeutic	therapeutic	ADJ
gra-819	81	11	part	part	NOUN
gra-819	81	12	/	/	SYM
gra-819	81	13	response	response	NOUN
gra-819	81	14	in	in	ADP
gra-819	81	15	our	our	PRON
gra-819	81	16	patients	patient	NOUN
gra-819	81	17	,	,	PUNCT
gra-819	81	18	no	no	DET
gra-819	81	19	comparison	comparison	NOUN
gra-819	81	20	with	with	ADP
gra-819	81	21	healthy	healthy	ADJ
gra-819	81	22	control	control	NOUN
gra-819	81	23	and	and	CCONJ
gra-819	81	24	also	also	ADV
gra-819	81	25	the	the	DET
gra-819	81	26	sample	sample	NOUN
gra-819	81	27	size	size	NOUN
gra-819	81	28	was	be	AUX
gra-819	81	29	not	not	PART
gra-819	81	30	adequate	adequate	ADJ
gra-819	81	31	to	to	PART
gra-819	81	32	derive	derive	VERB
gra-819	81	33	any	any	DET
gra-819	81	34	nal	nal	ADJ
gra-819	81	35	conclusion	conclusion	NOUN
gra-819	81	36	.	.	PUNCT
gra-819	82	1	acknowledgement	acknowledgement	NOUN
gra-819	82	2	:	:	PUNCT
gra-819	82	3	for	for	ADP
gra-819	82	4	statistical	statistical	ADJ
gra-819	82	5	analysis.dr	analysis.dr	PROPN
gra-819	82	6	triptish	triptish	PROPN
gra-819	82	7	bhatia	bhatia	PROPN
gra-819	82	8	,	,	PUNCT
gra-819	82	9	ph.d	ph.d	PROPN
gra-819	82	10	.	.	PUNCT
gra-819	83	1	senior	senior	ADJ
gra-819	83	2	research	research	NOUN
gra-819	83	3	scientist	scientist	NOUN
gra-819	83	4	,	,	PUNCT
gra-819	83	5	indo	indo	PROPN
gra-819	83	6	-	-	PUNCT
gra-819	83	7	us	us	PROPN
gra-819	83	8	projects	project	NOUN
gra-819	83	9	,	,	PUNCT
gra-819	83	10	dept	dept	NOUN
gra-819	83	11	.	.	PROPN
gra-819	83	12	of	of	ADP
gra-819	83	13	psychiatry	psychiatry	NOUN
gra-819	83	14	,	,	PUNCT
gra-819	83	15	center	center	NOUN
gra-819	83	16	of	of	ADP
gra-819	83	17	excellence	excellence	NOUN
gra-819	83	18	in	in	ADP
gra-819	83	19	mental	mental	ADJ
gra-819	83	20	health	health	NOUN
gra-819	83	21	,	,	PUNCT
gra-819	83	22	pgimer	pgimer	NOUN
gra-819	83	23	,	,	PUNCT
gra-819	83	24	dr	dr	PROPN
gra-819	83	25	rmlh	rmlh	PROPN
gra-819	83	26	,	,	PUNCT
gra-819	83	27	new	new	PROPN
gra-819	83	28	delhi	delhi	PROPN
gra-819	83	29	,	,	PUNCT
gra-819	83	30	india	india	PROPN
gra-819	83	31	.	.	PUNCT
gra-819	84	1	table1	table1	PROPN
gra-819	84	2	.	.	PUNCT
gra-819	85	1	showing	show	VERB
gra-819	85	2	demographic	demographic	ADJ
gra-819	85	3	and	and	CCONJ
gra-819	85	4	clinical	clinical	ADJ
gra-819	85	5	prole	prole	PROPN
gra-819	85	6	table	table	NOUN
gra-819	85	7	2	2	NUM
gra-819	85	8	.	.	PUNCT
gra-819	85	9	percentage	percentage	NOUN
gra-819	85	10	of	of	ADP
gra-819	85	11	patients	patient	NOUN
gra-819	85	12	with	with	ADP
gra-819	85	13	positive	positive	ADJ
gra-819	85	14	inammatory	inammatory	ADJ
gra-819	85	15	and	and	CCONJ
gra-819	85	16	autoimmune	autoimmune	ADJ
gra-819	85	17	markers	marker	NOUN
gra-819	85	18	.	.	PUNCT
gra-819	86	1	esrerythrocyte	esrerythrocyte	NOUN
gra-819	86	2	sedimentation	sedimentation	NOUN
gra-819	86	3	rate	rate	NOUN
gra-819	86	4	,	,	PUNCT
gra-819	86	5	crp	crp	PROPN
gra-819	86	6	-	-	PUNCT
gra-819	86	7	c	c	NOUN
gra-819	86	8	-	-	PUNCT
gra-819	86	9	reactive	reactive	ADJ
gra-819	86	10	protein	protein	NOUN
gra-819	86	11	,	,	PUNCT
gra-819	86	12	asoantistreptolysin	asoantistreptolysin	NOUN
gra-819	86	13	o	o	NOUN
gra-819	86	14	,	,	PUNCT
gra-819	86	15	aecabsolute	aecabsolute	VERB
gra-819	86	16	eosinophil	eosinophil	ADJ
gra-819	86	17	count	count	NOUN
gra-819	86	18	,	,	PUNCT
gra-819	86	19	total	total	ADJ
gra-819	86	20	leukocyte	leukocyte	NOUN
gra-819	86	21	count	count	NOUN
gra-819	86	22	anaantinuclear	anaantinuclear	ADJ
gra-819	86	23	antibodies	antibody	NOUN
gra-819	86	24	,	,	PUNCT
gra-819	86	25	anti	anti	ADJ
gra-819	86	26	-	-	ADJ
gra-819	86	27	tpoanti	tpoanti	ADJ
gra-819	86	28	thyroid	thyroid	NOUN
gra-819	86	29	peroxidise	peroxidise	ADV
gra-819	86	30	,	,	PUNCT
gra-819	86	31	asstautologus	asstautologus	ADJ
gra-819	86	32	serum	serum	NOUN
gra-819	86	33	skin	skin	NOUN
gra-819	86	34	test	test	NOUN
gra-819	86	35	,	,	PUNCT
gra-819	86	36	rfrheumatoid	rfrheumatoid	NOUN
gra-819	86	37	factor	factor	NOUN
gra-819	86	38	volume-8	volume-8	NUM
gra-819	86	39	,	,	PUNCT
gra-819	86	40	issue-11	issue-11	PROPN
gra-819	86	41	,	,	PUNCT
gra-819	86	42	november-2019	november-2019	ADJ
gra-819	86	43	•	•	NOUN
gra-819	86	44	print	print	NOUN
gra-819	86	45	issn	issn	PROPN
gra-819	86	46	no	no	NOUN
gra-819	86	47	.	.	PROPN
gra-819	86	48	2277	2277	NUM
gra-819	86	49	8160	8160	NUM
gra-819	86	50	•	•	NOUN
gra-819	86	51	doi	doi	NOUN
gra-819	86	52	:	:	PUNCT
gra-819	86	53	10.36106	10.36106	NUM
gra-819	86	54	/	/	SYM
gra-819	86	55	gjra	gjra	NOUN
gra-819	86	56	sex	sex	NOUN
gra-819	86	57	males	male	NOUN
gra-819	86	58	females	female	NOUN
gra-819	86	59	number	number	NOUN
gra-819	86	60	of	of	ADP
gra-819	86	61	patients	patient	NOUN
gra-819	86	62	(	(	PUNCT
gra-819	86	63	%	%	INTJ
gra-819	86	64	)	)	PUNCT
gra-819	86	65	(	(	PUNCT
gra-819	86	66	n=134	n=134	PROPN
gra-819	86	67	)	)	PUNCT
gra-819	86	68	42	42	NUM
gra-819	86	69	(	(	PUNCT
gra-819	86	70	31.3	31.3	NUM
gra-819	86	71	%	%	NOUN
gra-819	86	72	)	)	PUNCT
gra-819	86	73	92	92	NUM
gra-819	86	74	(	(	PUNCT
gra-819	86	75	68.7	68.7	NUM
gra-819	86	76	%	%	NOUN
gra-819	86	77	)	)	PUNCT
gra-819	86	78	mean±sd	mean±sd	ADP
gra-819	86	79	52.17	52.17	NUM
gra-819	86	80	+	+	NOUN
gra-819	86	81	83.46	83.46	NUM
gra-819	86	82	31.20	31.20	NUM
gra-819	86	83	+	+	SYM
gra-819	86	84	41.75	41.75	NUM
gra-819	86	85	age	age	NOUN
gra-819	86	86	(	(	PUNCT
gra-819	86	87	years	year	NOUN
gra-819	86	88	)	)	PUNCT
gra-819	86	89	range	range	NOUN
gra-819	86	90	14	14	NUM
gra-819	86	91	-	-	SYM
gra-819	86	92	72	72	NUM
gra-819	86	93	35.45±11.94	35.45±11.94	NUM
gra-819	86	94	duration(months	duration(month	NOUN
gra-819	86	95	)	)	PUNCT
gra-819	86	96	range	range	NOUN
gra-819	86	97	2	2	NUM
gra-819	86	98	-	-	SYM
gra-819	86	99	360	360	NUM
gra-819	86	100	37.77±58.61	37.77±58.61	NUM
gra-819	86	101	severity	severity	NOUN
gra-819	86	102	of	of	ADP
gra-819	86	103	urticaria	urticaria	NOUN
gra-819	86	104	(	(	PUNCT
gra-819	86	105	uas7	uas7	ADJ
gra-819	86	106	)	)	PUNCT
gra-819	86	107	mild	mild	ADJ
gra-819	86	108	moderate	moderate	ADJ
gra-819	86	109	severe	severe	ADJ
gra-819	86	110	19	19	NUM
gra-819	86	111	(	(	PUNCT
gra-819	86	112	14.2	14.2	NUM
gra-819	86	113	%	%	NOUN
gra-819	86	114	)	)	PUNCT
gra-819	86	115	84	84	NUM
gra-819	86	116	(	(	PUNCT
gra-819	86	117	62.2	62.2	NUM
gra-819	86	118	%	%	NOUN
gra-819	86	119	)	)	PUNCT
gra-819	86	120	31	31	NUM
gra-819	86	121	(	(	PUNCT
gra-819	86	122	23.1	23.1	NUM
gra-819	86	123	%	%	NOUN
gra-819	86	124	)	)	PUNCT
gra-819	87	1	27.54±8.364	27.54±8.364	NUM
gra-819	87	2	inammatory	inammatory	ADJ
gra-819	87	3	markers	marker	NOUN
gra-819	87	4	positive	positive	ADJ
gra-819	87	5	(	(	PUNCT
gra-819	87	6	no	no	INTJ
gra-819	87	7	.	.	NOUN
gra-819	87	8	of	of	ADP
gra-819	87	9	patients	patient	NOUN
gra-819	87	10	,	,	PUNCT
gra-819	87	11	%	%	INTJ
gra-819	87	12	)	)	PUNCT
gra-819	87	13	n=134	n=134	PROPN
gra-819	87	14	autoimmune	autoimmune	ADJ
gra-819	87	15	markers	marker	NOUN
gra-819	87	16	positive	positive	ADJ
gra-819	87	17	(	(	PUNCT
gra-819	87	18	no	no	INTJ
gra-819	87	19	.	.	NOUN
gra-819	87	20	of	of	ADP
gra-819	87	21	patients	patient	NOUN
gra-819	87	22	,	,	PUNCT
gra-819	87	23	%	%	INTJ
gra-819	87	24	)	)	PUNCT
gra-819	87	25	n=134	n=134	PROPN
gra-819	87	26	esr	esr	PROPN
gra-819	87	27	32	32	NUM
gra-819	87	28	(	(	PUNCT
gra-819	87	29	25	25	NUM
gra-819	87	30	%	%	NOUN
gra-819	87	31	)	)	PUNCT
gra-819	87	32	ana	ana	PROPN
gra-819	87	33	20	20	NUM
gra-819	87	34	(	(	PUNCT
gra-819	87	35	14.9	14.9	NUM
gra-819	87	36	%	%	NOUN
gra-819	87	37	)	)	PUNCT
gra-819	87	38	crp	crp	PROPN
gra-819	87	39	49	49	NUM
gra-819	87	40	(	(	PUNCT
gra-819	87	41	36.6	36.6	NUM
gra-819	87	42	%	%	NOUN
gra-819	87	43	)	)	PUNCT
gra-819	87	44	antitpo	antitpo	NOUN
gra-819	87	45	antibodies	antibodie	VERB
gra-819	87	46	31	31	NUM
gra-819	87	47	(	(	PUNCT
gra-819	87	48	23.5	23.5	NUM
gra-819	87	49	%	%	NOUN
gra-819	87	50	)	)	PUNCT
gra-819	87	51	aso	aso	NOUN
gra-819	87	52	11	11	NUM
gra-819	87	53	(	(	PUNCT
gra-819	87	54	8.2	8.2	NUM
gra-819	87	55	%	%	NOUN
gra-819	87	56	)	)	PUNCT
gra-819	87	57	asst	asst	NOUN
gra-819	87	58	40	40	NUM
gra-819	87	59	(	(	PUNCT
gra-819	87	60	29.9	29.9	NUM
gra-819	87	61	%	%	NOUN
gra-819	87	62	)	)	PUNCT
gra-819	87	63	aec	aec	PROPN
gra-819	87	64	24	24	NUM
gra-819	87	65	(	(	PUNCT
gra-819	87	66	17.9	17.9	NUM
gra-819	87	67	%	%	NOUN
gra-819	87	68	)	)	PUNCT
gra-819	87	69	rf	rf	NUM
gra-819	87	70	20	20	NUM
gra-819	87	71	(	(	PUNCT
gra-819	87	72	14.9	14.9	NUM
gra-819	87	73	%	%	NOUN
gra-819	87	74	)	)	PUNCT
gra-819	87	75	tlc	tlc	VERB
gra-819	87	76	7	7	NUM
gra-819	87	77	(	(	PUNCT
gra-819	87	78	5.2	5.2	NUM
gra-819	87	79	%	%	NOUN
gra-819	87	80	)	)	PUNCT
gra-819	88	1	s.	s.	PROPN
gra-819	88	2	ige	ige	PROPN
gra-819	88	3	82	82	PROPN
gra-819	88	4	(	(	PUNCT
gra-819	88	5	61.2	61.2	NUM
gra-819	88	6	%	%	NOUN
gra-819	88	7	)	)	PUNCT
gra-819	88	8	table	table	NOUN
gra-819	88	9	3	3	NUM
gra-819	88	10	.	.	PUNCT
gra-819	88	11	signicant	signicant	ADJ
gra-819	88	12	correlation	correlation	NOUN
gra-819	88	13	between	between	ADP
gra-819	88	14	various	various	ADJ
gra-819	88	15	clinical	clinical	ADJ
gra-819	88	16	and	and	CCONJ
gra-819	88	17	laboratory	laboratory	NOUN
gra-819	88	18	parameters	parameter	NOUN
gra-819	88	19	.	.	PUNCT
gra-819	89	1	inammatory	inammatory	ADJ
gra-819	89	2	markers	marker	NOUN
gra-819	89	3	with	with	ADP
gra-819	89	4	demographic	demographic	ADJ
gra-819	89	5	and	and	CCONJ
gra-819	89	6	autoimmune	autoimmune	ADJ
gra-819	89	7	parameters	parameter	NOUN
gra-819	89	8	*	*	PUNCT
gra-819	89	9	p	p	NOUN
gra-819	89	10	value	value	NOUN
gra-819	89	11	autoimmune	autoimmune	ADJ
gra-819	89	12	markers	marker	NOUN
gra-819	89	13	with	with	ADP
gra-819	89	14	demographic	demographic	ADJ
gra-819	89	15	and	and	CCONJ
gra-819	89	16	inammatory	inammatory	ADJ
gra-819	89	17	parameters	parameter	NOUN
gra-819	89	18	*	*	PUNCT
gra-819	89	19	p	p	NOUN
gra-819	89	20	value	value	NOUN
gra-819	89	21	demographic	demographic	ADJ
gra-819	89	22	with	with	ADP
gra-819	89	23	autoimmune	autoimmune	ADJ
gra-819	89	24	and	and	CCONJ
gra-819	89	25	inammatory	inammatory	ADJ
gra-819	89	26	parameters	parameter	NOUN
gra-819	89	27	*	*	PUNCT
gra-819	89	28	p	p	NOUN
gra-819	89	29	value	value	NOUN
gra-819	89	30	esr	esr	PROPN
gra-819	89	31	stool	stool	NOUN
gra-819	89	32	for	for	ADP
gra-819	89	33	ova	ova	NOUN
gra-819	89	34	and	and	CCONJ
gra-819	89	35	cyst	cyst	VERB
gra-819	89	36	0.027	0.027	NUM
gra-819	89	37	ana	ana	PROPN
gra-819	89	38	duration	duration	NOUN
gra-819	89	39	0.000	0.000	NUM
gra-819	89	40	duration	duration	NOUN
gra-819	89	41	ana	ana	PROPN
gra-819	89	42	0.000	0.000	NUM
gra-819	89	43	x	x	SYM
gra-819	89	44	45gjra	45gjra	PUNCT
gra-819	89	45	global	global	ADJ
gra-819	89	46	journal	journal	PROPN
gra-819	89	47	for	for	ADP
gra-819	89	48	research	research	NOUN
gra-819	89	49	analysis	analysis	NOUN
gra-819	89	50	*	*	PUNCT
gra-819	89	51	p	p	NOUN
gra-819	89	52	value	value	NOUN
gra-819	89	53	signicant	signicant	ADJ
gra-819	89	54	below	below	ADP
gra-819	89	55	0.05	0.05	NUM
gra-819	89	56	level	level	NOUN
gra-819	89	57	,	,	PUNCT
gra-819	89	58	esrerythrocyte	esrerythrocyte	NOUN
gra-819	89	59	sedimentation	sedimentation	NOUN
gra-819	89	60	rate	rate	NOUN
gra-819	89	61	,	,	PUNCT
gra-819	89	62	crpc	crpc	ADJ
gra-819	89	63	-	-	PUNCT
gra-819	89	64	reactive	reactive	ADJ
gra-819	89	65	protein	protein	NOUN
gra-819	89	66	,	,	PUNCT
gra-819	89	67	uasurticaria	uasurticaria	PROPN
gra-819	89	68	activity	activity	NOUN
gra-819	89	69	score	score	NOUN
gra-819	89	70	,	,	PUNCT
gra-819	89	71	tlctotal	tlctotal	ADJ
gra-819	89	72	leukocyte	leukocyte	NOUN
gra-819	89	73	count	count	NOUN
gra-819	89	74	,	,	PUNCT
gra-819	89	75	aecabsolute	aecabsolute	ADJ
gra-819	89	76	eosinophil	eosinophil	ADJ
gra-819	89	77	count	count	NOUN
gra-819	89	78	,	,	PUNCT
gra-819	89	79	ana	ana	PROPN
gra-819	89	80	-	-	PUNCT
gra-819	89	81	antinuclear	antinuclear	ADJ
gra-819	89	82	antibodies	antibodie	VERB
gra-819	89	83	,	,	PUNCT
gra-819	89	84	asstautologus	asstautologus	ADJ
gra-819	89	85	serum	serum	NOUN
gra-819	89	86	skin	skin	NOUN
gra-819	89	87	test	test	NOUN
gra-819	89	88	,	,	PUNCT
gra-819	89	89	rfrheumatoid	rfrheumatoid	NOUN
gra-819	89	90	factor	factor	NOUN
gra-819	89	91	references	reference	NOUN
gra-819	89	92	1	1	NUM
gra-819	89	93	.	.	PUNCT
gra-819	89	94	sabron	sabron	PROPN
gra-819	89	95	ra	ra	PROPN
gra-819	89	96	,	,	PUNCT
gra-819	89	97	grattance	grattance	PROPN
gra-819	89	98	,	,	PUNCT
gra-819	89	99	francis	francis	PROPN
gra-819	89	100	dm	dm	PROPN
gra-819	89	101	,	,	PUNCT
gra-819	89	102	barr	barr	PROPN
gra-819	89	103	rm	rm	PROPN
gra-819	89	104	,	,	PUNCT
gra-819	89	105	kobza	kobza	VERB
gra-819	89	106	black	black	PROPN
gra-819	89	107	a	a	PROPN
gra-819	89	108	,	,	PUNCT
gra-819	89	109	greaves	greave	NOUN
gra-819	89	110	mw	mw	X
gra-819	89	111	.	.	PUNCT
gra-819	90	1	the	the	DET
gra-819	90	2	autologous	autologous	ADJ
gra-819	90	3	serum	serum	NOUN
gra-819	90	4	skin	skin	NOUN
gra-819	90	5	test	test	NOUN
gra-819	90	6	:	:	PUNCT
gra-819	90	7	a	a	DET
gra-819	90	8	screening	screening	NOUN
gra-819	90	9	test	test	NOUN
gra-819	90	10	for	for	ADP
gra-819	90	11	autoantibodies	autoantibody	NOUN
gra-819	90	12	in	in	ADP
gra-819	90	13	chronic	chronic	ADJ
gra-819	90	14	idiopathic	idiopathic	ADJ
gra-819	90	15	urticaria	urticaria	NOUN
gra-819	90	16	.	.	PUNCT
gra-819	91	1	br	br	PROPN
gra-819	91	2	dermatol	dermatol	NOUN
gra-819	91	3	1999	1999	NUM
gra-819	91	4	;	;	PUNCT
gra-819	91	5	140:446	140:446	NUM
gra-819	91	6	-	-	SYM
gra-819	91	7	52	52	NUM
gra-819	91	8	.	.	NOUN
gra-819	92	1	2	2	X
gra-819	92	2	.	.	X
gra-819	92	3	hide	hide	VERB
gra-819	92	4	m	m	PROPN
gra-819	92	5	,	,	PUNCT
gra-819	92	6	francis	francis	PROPN
gra-819	92	7	dm	dm	PROPN
gra-819	92	8	,	,	PUNCT
gra-819	92	9	grattan	grattan	PROPN
gra-819	92	10	ceh	ceh	PROPN
gra-819	92	11	,	,	PUNCT
gra-819	92	12	hakimi	hakimi	PROPN
gra-819	92	13	j	j	PROPN
gra-819	92	14	,	,	PUNCT
gra-819	92	15	kochan	kochan	PROPN
gra-819	92	16	jp	jp	PROPN
gra-819	92	17	,	,	PUNCT
gra-819	92	18	greaves	greave	VERB
gra-819	92	19	mw	mw	PROPN
gra-819	92	20	.	.	PROPN
gra-819	92	21	auto	auto	NOUN
gra-819	92	22	antibodies	antibody	NOUN
gra-819	92	23	against	against	ADP
gra-819	92	24	the	the	DET
gra-819	92	25	high	high	ADJ
gra-819	92	26	afnity	afnity	NOUN
gra-819	92	27	ige	ige	NOUN
gra-819	92	28	receptor	receptor	NOUN
gra-819	92	29	as	as	ADP
gra-819	92	30	a	a	DET
gra-819	92	31	cause	cause	NOUN
gra-819	92	32	of	of	ADP
gra-819	92	33	histamine	histamine	NOUN
gra-819	92	34	release	release	NOUN
gra-819	92	35	in	in	ADP
gra-819	92	36	chronic	chronic	ADJ
gra-819	92	37	urticaria	urticaria	NOUN
gra-819	92	38	.	.	PUNCT
gra-819	93	1	n	n	PROPN
gra-819	93	2	eng	eng	PROPN
gra-819	93	3	j	j	PROPN
gra-819	93	4	med	med	PROPN
gra-819	93	5	1993	1993	NUM
gra-819	93	6	;	;	PUNCT
gra-819	93	7	328:1599	328:1599	X
gra-819	93	8	-	-	SYM
gra-819	93	9	604	604	NUM
gra-819	93	10	.	.	PUNCT
gra-819	94	1	3	3	X
gra-819	94	2	.	.	PUNCT
gra-819	95	1	conno	conno	PROPN
gra-819	95	2	cohen	cohen	PROPN
gra-819	95	3	r	r	NOUN
gra-819	95	4	,	,	PUNCT
gra-819	95	5	chodick	chodick	NOUN
gra-819	95	6	g	g	PROPN
gra-819	95	7	,	,	PUNCT
gra-819	95	8	shalev	shalev	NOUN
gra-819	95	9	v	v	ADP
gra-819	95	10	et	et	PROPN
gra-819	95	11	al	al	PROPN
gra-819	95	12	.	.	PROPN
gra-819	96	1	chronic	chronic	ADJ
gra-819	96	2	urticaria	urticaria	NOUN
gra-819	96	3	and	and	CCONJ
gra-819	96	4	autoimmunity	autoimmunity	NOUN
gra-819	96	5	:	:	PUNCT
gra-819	96	6	associations	association	NOUN
gra-819	96	7	found	find	VERB
gra-819	96	8	in	in	ADP
gra-819	96	9	a	a	DET
gra-819	96	10	large	large	ADJ
gra-819	96	11	population	population	NOUN
gra-819	96	12	study	study	NOUN
gra-819	96	13	.	.	PUNCT
gra-819	97	1	j	j	PROPN
gra-819	97	2	allergy	allergy	PROPN
gra-819	97	3	clin	clin	PROPN
gra-819	97	4	immunol	immunol	PROPN
gra-819	97	5	.	.	PUNCT
gra-819	98	1	2012	2012	NUM
gra-819	98	2	;	;	PUNCT
gra-819	99	1	129(5):1307	129(5):1307	X
gra-819	99	2	-	-	SYM
gra-819	99	3	13	13	NUM
gra-819	99	4	.	.	PUNCT
gra-819	99	5	4	4	X
gra-819	99	6	.	.	X
gra-819	100	1	atta	atta	PROPN
gra-819	100	2	am	be	AUX
gra-819	100	3	,	,	PUNCT
gra-819	100	4	rodriguesmza	rodriguesmza	PROPN
gra-819	100	5	,	,	PUNCT
gra-819	100	6	sousa	sousa	PROPN
gra-819	100	7	cp	cp	PROPN
gra-819	100	8	,	,	PUNCT
gra-819	100	9	medeiros	medeiros	PROPN
gra-819	100	10	junior	junior	PROPN
gra-819	100	11	m	m	PROPN
gra-819	100	12	,	,	PUNCT
gra-819	100	13	sousa	sousa	NOUN
gra-819	100	14	-	-	PUNCT
gra-819	100	15	atta	atta	PROPN
gra-819	100	16	mlb	mlb	NOUN
gra-819	100	17	.	.	PUNCT
gra-819	101	1	autoantibodies	autoantibody	NOUN
gra-819	101	2	production	production	NOUN
gra-819	101	3	in	in	ADP
gra-819	101	4	chronic	chronic	ADJ
gra-819	101	5	idiopathic	idiopathic	ADJ
gra-819	101	6	urticaria	urticaria	NOUN
gra-819	101	7	is	be	AUX
gra-819	101	8	not	not	PART
gra-819	101	9	associated	associate	VERB
gra-819	101	10	with	with	ADP
gra-819	101	11	helicobacter	helicobacter	NOUN
gra-819	101	12	pylori	pylori	ADJ
gra-819	101	13	infection	infection	NOUN
gra-819	101	14	.	.	PUNCT
gra-819	102	1	braz	braz	PROPN
gra-819	102	2	j	j	PROPN
gra-819	102	3	med	med	PROPN
gra-819	102	4	biol	biol	PROPN
gra-819	102	5	res	re	VERB
gra-819	102	6	2004;37:13	2004;37:13	NUM
gra-819	102	7	-	-	SYM
gra-819	102	8	7	7	NUM
gra-819	102	9	.	.	NOUN
gra-819	102	10	5	5	NUM
gra-819	102	11	.	.	X
gra-819	103	1	aamir	aamir	PROPN
gra-819	103	2	is	be	AUX
gra-819	103	3	,	,	PUNCT
gra-819	103	4	tauheed	tauhee	VERB
gra-819	103	5	s	s	PROPN
gra-819	103	6	,	,	PUNCT
gra-819	103	7	majid	majid	PROPN
gra-819	103	8	f	f	PROPN
gra-819	103	9	,	,	PUNCT
gra-819	103	10	atif	atif	PROPN
gra-819	103	11	a.	a.	NOUN
gra-819	103	12	frequency	frequency	NOUN
gra-819	103	13	of	of	ADP
gra-819	103	14	autoimmunethyroid	autoimmunethyroid	PROPN
gra-819	103	15	disease	disease	NOUN
gra-819	103	16	in	in	ADP
gra-819	103	17	chronic	chronic	ADJ
gra-819	103	18	urticaria	urticaria	NOUN
gra-819	103	19	.	.	PUNCT
gra-819	104	1	j	j	PROPN
gra-819	104	2	coll	coll	PROPN
gra-819	104	3	physicians	physicians	PROPN
gra-819	104	4	surg	surg	PROPN
gra-819	104	5	pak	pak	VERB
gra-819	104	6	2010;20:158	2010;20:158	PROPN
gra-819	104	7	-	-	SYM
gra-819	104	8	61	61	NUM
gra-819	104	9	.	.	PUNCT
gra-819	105	1	6	6	NUM
gra-819	105	2	.	.	PUNCT
gra-819	106	1	kessel	kessel	PROPN
gra-819	106	2	a	a	PROPN
gra-819	106	3	,	,	PUNCT
gra-819	106	4	helou	helou	NOUN
gra-819	106	5	w	w	PROPN
gra-819	106	6	,	,	PUNCT
gra-819	106	7	bamberger	bamberger	NOUN
gra-819	106	8	e	e	NOUN
gra-819	106	9	,	,	PUNCT
gra-819	106	10	sabo	sabo	NOUN
gra-819	106	11	e	e	PROPN
gra-819	106	12	,	,	PUNCT
gra-819	106	13	nusem	nusem	PROPN
gra-819	106	14	d	d	PROPN
gra-819	106	15	,	,	PUNCT
gra-819	106	16	panassof	panassof	PROPN
gra-819	106	17	j	j	PROPN
gra-819	106	18	,	,	PUNCT
gra-819	106	19	toubi	toubi	PROPN
gra-819	106	20	e.	e.	PROPN
gra-819	106	21	elevated	elevated	PROPN
gra-819	106	22	serum	serum	PROPN
gra-819	106	23	total	total	PROPN
gra-819	106	24	igea	igea	ADJ
gra-819	106	25	potential	potential	ADJ
gra-819	106	26	marker	marker	NOUN
gra-819	106	27	for	for	ADP
gra-819	106	28	severe	severe	ADJ
gra-819	106	29	chronic	chronic	ADJ
gra-819	106	30	urticaria	urticaria	NOUN
gra-819	106	31	.	.	PUNCT
gra-819	107	1	int	int	PROPN
gra-819	107	2	arch	arch	ADJ
gra-819	107	3	allergy	allergy	PROPN
gra-819	107	4	immunol	immunol	PROPN
gra-819	107	5	2010	2010	NUM
gra-819	107	6	;	;	PUNCT
gra-819	107	7	153:288	153:288	NUM
gra-819	107	8	-	-	PUNCT
gra-819	107	9	93	93	NUM
gra-819	107	10	.	.	PUNCT
gra-819	108	1	7	7	X
gra-819	108	2	.	.	NUM
gra-819	108	3	kasperska	kasperska	PROPN
gra-819	108	4	-	-	PUNCT
gra-819	108	5	zajaca	zajaca	NOUN
gra-819	108	6	,	,	PUNCT
gra-819	108	7	acute	acute	ADJ
gra-819	108	8	-	-	PUNCT
gra-819	108	9	phase	phase	NOUN
gra-819	108	10	response	response	NOUN
gra-819	108	11	in	in	ADP
gra-819	108	12	chronic	chronic	ADJ
gra-819	108	13	urticaria	urticaria	NOUN
gra-819	108	14	.	.	PUNCT
gra-819	109	1	j	j	PROPN
gra-819	109	2	eur	eur	PROPN
gra-819	109	3	acad	acad	PROPN
gra-819	109	4	dermatol	dermatol	NOUN
gra-819	109	5	venereol	venereol	NOUN
gra-819	109	6	.	.	PUNCT
gra-819	110	1	2012	2012	NUM
gra-819	110	2	;	;	PUNCT
gra-819	110	3	26:665	26:665	NUM
gra-819	110	4	-	-	SYM
gra-819	110	5	72	72	NUM
gra-819	110	6	.	.	NOUN
gra-819	110	7	8	8	NUM
gra-819	110	8	.	.	PUNCT
gra-819	111	1	wedi	wedi	PROPN
gra-819	111	2	b	b	PROPN
gra-819	111	3	,	,	PUNCT
gra-819	111	4	raap	raap	PROPN
gra-819	111	5	u	u	NOUN
gra-819	111	6	,	,	PUNCT
gra-819	111	7	weickzorek	weickzorek	PROPN
gra-819	111	8	d	d	NOUN
gra-819	111	9	,	,	PUNCT
gra-819	111	10	kaap	kaap	PROPN
gra-819	111	11	a.urticaria	a.urticaria	NOUN
gra-819	111	12	and	and	CCONJ
gra-819	111	13	infections	infection	NOUN
gra-819	111	14	.	.	PUNCT
gra-819	112	1	allergy	allergy	NOUN
gra-819	112	2	,	,	PUNCT
gra-819	112	3	asthma	asthma	PROPN
gra-819	112	4	&	&	CCONJ
gra-819	112	5	clinical	clinical	ADJ
gra-819	112	6	immunology	immunology	NOUN
gra-819	112	7	.	.	PUNCT
gra-819	112	8	2009	2009	NUM
gra-819	112	9	;	;	PUNCT
gra-819	112	10	5:10	5:10	NUM
gra-819	112	11	.	.	NOUN
gra-819	112	12	9	9	NUM
gra-819	112	13	.	.	X
gra-819	113	1	godsekv.urticariameter.indianjdermatol2012	godsekv.urticariameter.indianjdermatol2012	NOUN
gra-819	113	2	;	;	PUNCT
gra-819	113	3	57:410	57:410	NUM
gra-819	113	4	-	-	SYM
gra-819	113	5	1	1	NUM
gra-819	113	6	.	.	NOUN
gra-819	113	7	10	10	NUM
gra-819	113	8	.	.	PUNCT
gra-819	114	1	ghose	ghose	PROPN
gra-819	114	2	sk	sk	PROPN
gra-819	114	3	,	,	PUNCT
gra-819	114	4	ghosh	ghosh	PROPN
gra-819	114	5	s.	s.	PROPN
gra-819	115	1	autologous	autologous	ADJ
gra-819	115	2	seum	seum	PROPN
gra-819	115	3	skin	skin	NOUN
gra-819	115	4	test	test	NOUN
gra-819	115	5	.	.	PUNCT
gra-819	116	1	indian	indian	ADJ
gra-819	116	2	journal	journal	PROPN
gra-819	116	3	of	of	ADP
gra-819	116	4	dermatology	dermatology	NOUN
gra-819	116	5	.	.	PUNCT
gra-819	117	1	2009;54(1):86	2009;54(1):86	NUM
gra-819	117	2	-	-	SYM
gra-819	117	3	87	87	NUM
gra-819	117	4	.	.	PUNCT
gra-819	118	1	11	11	NUM
gra-819	118	2	.	.	X
gra-819	119	1	irinyi	irinyi	PROPN
gra-819	119	2	b	b	PROPN
gra-819	119	3	,	,	PUNCT
gra-819	119	4	sze	sze	PROPN
gra-819	119	5	ĺ	ĺ	PROPN
gra-819	119	6	es	es	X
gra-819	119	7	g	g	PROPN
gra-819	119	8	,	,	PUNCT
gra-819	119	9	gyimesi	gyimesi	NOUN
gra-819	119	10	e	e	PROPN
gra-819	119	11	,	,	PUNCT
gra-819	119	12	et	et	PROPN
gra-819	119	13	al	al	PROPN
gra-819	119	14	.	.	PROPN
gra-819	120	1	clinical	clinical	ADJ
gra-819	120	2	and	and	CCONJ
gra-819	120	3	laboratory	laboratory	NOUN
gra-819	120	4	examinations	examination	NOUN
gra-819	120	5	in	in	ADP
gra-819	120	6	the	the	DET
gra-819	120	7	subgroups	subgroup	NOUN
gra-819	120	8	of	of	ADP
gra-819	120	9	chronic	chronic	ADJ
gra-819	120	10	urticaria	urticaria	NOUN
gra-819	120	11	.	.	PUNCT
gra-819	121	1	int	int	PROPN
gra-819	121	2	arch	arch	ADJ
gra-819	121	3	allergy	allergy	NOUN
gra-819	121	4	immunol	immunol	NOUN
gra-819	121	5	144:217–225	144:217–225	NUM
gra-819	121	6	,	,	PUNCT
gra-819	121	7	2007	2007	NUM
gra-819	121	8	.	.	PUNCT
gra-819	122	1	12	12	NUM
gra-819	122	2	.	.	PUNCT
gra-819	123	1	magen	magen	PROPN
gra-819	123	2	e	e	PROPN
gra-819	123	3	,	,	PUNCT
gra-819	123	4	waitman	waitman	NOUN
gra-819	123	5	da	da	NOUN
gra-819	123	6	,	,	PUNCT
gra-819	123	7	dickstein	dickstein	ADV
gra-819	123	8	y	y	PROPN
gra-819	123	9	,	,	PUNCT
gra-819	123	10	davidovich	davidovich	VERB
gra-819	123	11	v	v	ADP
gra-819	123	12	,	,	PUNCT
gra-819	123	13	kahan	kahan	PROPN
gra-819	123	14	nr	nr	PROPN
gra-819	123	15	.	.	PROPN
gra-819	123	16	clinicallaboratory	clinicallaboratory	PROPN
gra-819	123	17	characteristics	characteristic	NOUN
gra-819	123	18	of	of	ADP
gra-819	123	19	ana	ana	PROPN
gra-819	123	20	-	-	PUNCT
gra-819	123	21	positive	positive	ADJ
gra-819	123	22	chronic	chronic	ADJ
gra-819	123	23	idiopathic	idiopathic	ADJ
gra-819	123	24	urticaria	urticaria	NOUN
gra-819	123	25	.	.	PUNCT
gra-819	124	1	allergy	allergy	PROPN
gra-819	124	2	asthma	asthma	PROPN
gra-819	124	3	proc.2015	proc.2015	PROPN
gra-819	124	4	mar	mar	PROPN
gra-819	124	5	-	-	PUNCT
gra-819	124	6	apr	apr	PROPN
gra-819	124	7	;	;	PUNCT
gra-819	124	8	36(2):138	36(2):138	NUM
gra-819	124	9	-	-	SYM
gra-819	124	10	44	44	NUM
gra-819	124	11	.	.	PUNCT
gra-819	124	12	13	13	NUM
gra-819	124	13	.	.	PUNCT
gra-819	125	1	george	george	PROPN
gra-819	125	2	m	m	PROPN
gra-819	125	3	,	,	PUNCT
gra-819	125	4	ba	ba	PROPN
gra-819	125	5	lachandran	lachandran	PROPN
gra-819	125	6	c	c	PROPN
gra-819	125	7	,	,	PUNCT
gra-819	125	8	prabhu	prabhu	PROPN
gra-819	125	9	s	s	PART
gra-819	125	10	.	.	PUNCT
gra-819	126	1	chron	chron	PROPN
gra-819	127	1	ic	ic	PROPN
gra-819	127	2	i	i	PROPN
gra-819	127	3	d	d	PROPN
gra-819	127	4	iopa	iopa	PROPN
gra-819	127	5	th	th	X
gra-819	127	6	ic	ic	PROPN
gra-819	127	7	urticaria	urticaria	PROPN
gra-819	127	8	:	:	PUNCT
gra-819	127	9	comparison	comparison	NOUN
gra-819	127	10	of	of	ADP
gra-819	127	11	clinical	clinical	ADJ
gra-819	127	12	features	feature	NOUN
gra-819	127	13	with	with	ADP
gra-819	127	14	positive	positive	ADJ
gra-819	127	15	autologus	autologus	NOUN
gra-819	127	16	serum	serum	NOUN
gra-819	127	17	skin	skin	NOUN
gra-819	127	18	test.indian	test.indian	PROPN
gra-819	127	19	j	j	PROPN
gra-819	127	20	dermatol	dermatol	NOUN
gra-819	127	21	venereol	venereol	NOUN
gra-819	127	22	leprol	leprol	NOUN
gra-819	127	23	2008;74:105	2008;74:105	PROPN
gra-819	127	24	-	-	SYM
gra-819	127	25	8	8	NUM
gra-819	127	26	14	14	NUM
gra-819	127	27	.	.	PUNCT
gra-819	128	1	viswanathan	viswanathan	PROPN
gra-819	128	2	rk	rk	NOUN
gra-819	128	3	,	,	PUNCT
gra-819	128	4	biagtan	biagtan	PROPN
gra-819	128	5	mj	mj	PROPN
gra-819	128	6	,	,	PUNCT
gra-819	128	7	and	and	CCONJ
gra-819	128	8	mathur	mathur	PROPN
gra-819	128	9	sk	sk	PROPN
gra-819	128	10	.	.	PUNCT
gra-819	129	1	the	the	DET
gra-819	129	2	role	role	NOUN
gra-819	129	3	of	of	ADP
gra-819	129	4	autoimmune	autoimmune	ADJ
gra-819	129	5	testing	testing	NOUN
gra-819	129	6	in	in	ADP
gra-819	129	7	chronic	chronic	ADJ
gra-819	129	8	idiopathic	idiopathic	ADJ
gra-819	129	9	urticaria	urticaria	NOUN
gra-819	129	10	.	.	PUNCT
gra-819	130	1	ann	ann	PROPN
gra-819	130	2	allergy	allergy	PROPN
gra-819	130	3	asthma	asthma	PROPN
gra-819	130	4	immunol	immunol	PROPN
gra-819	130	5	108:337–341.e1	108:337–341.e1	NUM
gra-819	130	6	,	,	PUNCT
gra-819	130	7	2012	2012	NUM
gra-819	130	8	15	15	NUM
gra-819	130	9	.	.	PUNCT
gra-819	131	1	toubi	toubi	PROPN
gra-819	131	2	e.	e.	PROPN
gra-819	131	3	kessel	kessel	PROPN
gra-819	131	4	a.	a.	PROPN
gra-819	131	5	avshovich	avshovich	PROPN
gra-819	131	6	n.	n.	PROPN
gra-819	131	7	bamberger	bamberger	PROPN
gra-819	131	8	e.	e.	PROPN
gra-819	131	9	sabo	sabo	PROPN
gra-819	131	10	e.	e.	PROPN
gra-819	131	11	nusem	nusem	PROPN
gra-819	131	12	d.	d.	PROPN
gra-819	131	13	panasoff	panasoff	PROPN
gra-819	131	14	j.clinical	j.clinical	ADJ
gra-819	131	15	and	and	CCONJ
gra-819	131	16	laboratory	laboratory	NOUN
gra-819	131	17	parameters	parameter	NOUN
gra-819	131	18	in	in	ADP
gra-819	131	19	predicting	predict	VERB
gra-819	131	20	chronic	chronic	ADJ
gra-819	131	21	urticaria	urticaria	NOUN
gra-819	131	22	duration	duration	NOUN
gra-819	131	23	:	:	PUNCT
gra-819	131	24	a	a	DET
gra-819	131	25	prospective	prospective	ADJ
gra-819	131	26	study	study	NOUN
gra-819	131	27	of	of	ADP
gra-819	131	28	139	139	NUM
gra-819	131	29	patients.allergy.2004	patients.allergy.2004	PROPN
gra-819	131	30	aug	aug	NOUN
gra-819	131	31	;	;	PUNCT
gra-819	131	32	59(8):869	59(8):869	NUM
gra-819	131	33	-	-	SYM
gra-819	131	34	73	73	NUM
gra-819	131	35	.	.	PUNCT
gra-819	132	1	16	16	NUM
gra-819	132	2	.	.	PUNCT
gra-819	133	1	caproni	caproni	PROPN
gra-819	133	2	m	m	PROPN
gra-819	133	3	,	,	PUNCT
gra-819	133	4	volpi	volpi	PROPN
gra-819	133	5	w	w	PROPN
gra-819	133	6	,	,	PUNCT
gra-819	133	7	giomi	giomi	NOUN
gra-819	133	8	b	b	NOUN
gra-819	133	9	,	,	PUNCT
gra-819	133	10	et	et	PROPN
gra-819	133	11	al	al	PROPN
gra-819	133	12	.	.	PROPN
gra-819	133	13	chronic	chronic	PROPN
gra-819	133	14	idiopathic	idiopathic	ADJ
gra-819	133	15	and	and	CCONJ
gra-819	133	16	chronic	chronic	ADJ
gra-819	133	17	autoimmune	autoimmune	ADJ
gra-819	133	18	urticaria	urticaria	NOUN
gra-819	133	19	:	:	PUNCT
gra-819	133	20	clinical	clinical	ADJ
gra-819	133	21	and	and	CCONJ
gra-819	133	22	immunopathological	immunopathological	ADJ
gra-819	133	23	features	feature	NOUN
gra-819	133	24	of	of	ADP
gra-819	133	25	68	68	NUM
gra-819	133	26	subjects	subject	NOUN
gra-819	133	27	.	.	PUNCT
gra-819	134	1	acta	acta	PROPN
gra-819	134	2	derm	derm	NOUN
gra-819	134	3	vererol	vererol	PROPN
gra-819	134	4	2004	2004	NUM
gra-819	134	5	;	;	PUNCT
gra-819	134	6	84:288–90	84:288–90	NOUN
gra-819	134	7	.	.	PUNCT
gra-819	135	1	17	17	NUM
gra-819	135	2	.	.	PUNCT
gra-819	136	1	rabelo	rabelo	NOUN
gra-819	136	2	-	-	PUNCT
gra-819	136	3	filardi	filardi	NOUN
gra-819	136	4	r.daltro	r.daltro	NOUN
gra-819	136	5	-	-	PUNCT
gra-819	136	6	oliveira	oliveira	PROPN
gra-819	136	7	r.campos	r.campos	NUM
gra-819	136	8	r.a	r.a	PROPN
gra-819	136	9	.	.	PROPN
gra-819	136	10	parameters	parameter	NOUN
gra-819	136	11	associated	associate	VERB
gra-819	136	12	with	with	ADP
gra-819	136	13	chronic	chronic	ADJ
gra-819	136	14	spontaneous	spontaneous	ADJ
gra-819	136	15	urticaria	urticaria	NOUN
gra-819	136	16	duration	duration	NOUN
gra-819	136	17	and	and	CCONJ
gra-819	136	18	severity	severity	NOUN
gra-819	136	19	:	:	PUNCT
gra-819	136	20	a	a	DET
gra-819	136	21	systematic	systematic	ADJ
gra-819	136	22	review	review	NOUN
gra-819	136	23	.	.	PUNCT
gra-819	137	1	int	int	PROPN
gra-819	137	2	arch	arch	ADJ
gra-819	137	3	allergy	allergy	PROPN
gra-819	137	4	immunol	immunol	PROPN
gra-819	137	5	2013	2013	NUM
gra-819	137	6	;	;	PUNCT
gra-819	137	7	161:197	161:197	NUM
gra-819	137	8	-	-	SYM
gra-819	137	9	204	204	NUM
gra-819	137	10	.	.	PUNCT
gra-819	138	1	18	18	NUM
gra-819	138	2	.	.	PUNCT
gra-819	139	1	kolkhir	kolkhir	PROPN
gra-819	139	2	p	p	NOUN
gra-819	139	3	,	,	PUNCT
gra-819	139	4	altrichter	altrichter	PROPN
gra-819	139	5	s	s	PROPN
gra-819	139	6	,	,	PUNCT
gra-819	139	7	hawro	hawro	PROPN
gra-819	139	8	t	t	PROPN
gra-819	139	9	,	,	PUNCT
gra-819	139	10	maurer	maurer	PROPN
gra-819	139	11	m.	m.	PROPN
gra-819	139	12	c	c	NOUN
gra-819	139	13	-	-	PUNCT
gra-819	139	14	reactive	reactive	ADJ
gra-819	139	15	protein	protein	NOUN
gra-819	139	16	is	be	AUX
gra-819	139	17	linked	link	VERB
gra-819	139	18	to	to	ADP
gra-819	139	19	disease	disease	NOUN
gra-819	139	20	activity	activity	NOUN
gra-819	139	21	,	,	PUNCT
gra-819	139	22	impact	impact	NOUN
gra-819	139	23	,	,	PUNCT
gra-819	139	24	and	and	CCONJ
gra-819	139	25	response	response	NOUN
gra-819	139	26	to	to	ADP
gra-819	139	27	treatment	treatment	NOUN
gra-819	139	28	in	in	ADP
gra-819	139	29	patients	patient	NOUN
gra-819	139	30	with	with	ADP
gra-819	139	31	chronic	chronic	ADJ
gra-819	139	32	spontaneous	spontaneous	ADJ
gra-819	139	33	urticaria	urticaria	NOUN
gra-819	139	34	.	.	PUNCT
gra-819	140	1	allergy.2018	allergy.2018	NOUN
gra-819	140	2	apr	apr	NOUN
gra-819	140	3	;	;	PUNCT
gra-819	140	4	73(4):940	73(4):940	NOUN
gra-819	140	5	-	-	SYM
gra-819	140	6	48	48	NUM
gra-819	140	7	.	.	PUNCT
gra-819	141	1	19	19	NUM
gra-819	141	2	.	.	PUNCT
gra-819	141	3	grennan	grennan	PROPN
gra-819	141	4	dm	dm	PROPN
gra-819	141	5	,	,	PUNCT
gra-819	141	6	palmer	palmer	PROPN
gra-819	141	7	dg	dg	PROPN
gra-819	141	8	.	.	PUNCT
gra-819	142	1	serum	serum	PROPN
gra-819	142	2	ige	ige	PROPN
gra-819	142	3	concentration	concentration	NOUN
gra-819	142	4	in	in	ADP
gra-819	142	5	rheumatoid	rheumatoid	NOUN
gra-819	142	6	arthritis	arthritis	NOUN
gra-819	142	7	:	:	PUNCT
gra-819	142	8	lack	lack	NOUN
gra-819	142	9	of	of	ADP
gra-819	142	10	correlation	correlation	NOUN
gra-819	142	11	with	with	ADP
gra-819	142	12	gold	gold	ADJ
gra-819	142	13	toxicity	toxicity	NOUN
gra-819	142	14	.	.	PUNCT
gra-819	143	1	br	br	PROPN
gra-819	143	2	med	med	PROPN
gra-819	143	3	j.	j.	PROPN
gra-819	143	4	1979;2:1477–8	1979;2:1477–8	PROPN
gra-819	143	5	.	.	PROPN
gra-819	144	1	20	20	NUM
gra-819	144	2	.	.	PUNCT
gra-819	145	1	hunder	hunder	NOUN
gra-819	145	2	gg	gg	PROPN
gra-819	145	3	,	,	PUNCT
gra-819	145	4	gleich	gleich	PROPN
gra-819	145	5	gj	gj	PROPN
gra-819	145	6	.	.	PUNCT
gra-819	146	1	immunoglobulin	immunoglobulin	PROPN
gra-819	146	2	e	e	PROPN
gra-819	146	3	(	(	PUNCT
gra-819	146	4	ige	ige	PROPN
gra-819	146	5	)	)	PUNCT
gra-819	146	6	levels	level	NOUN
gra-819	146	7	in	in	ADP
gra-819	146	8	serum	serum	NOUN
gra-819	146	9	and	and	CCONJ
gra-819	146	10	synovial	synovial	ADJ
gra-819	146	11	uid	uid	NOUN
gra-819	146	12	in	in	ADP
gra-819	146	13	rheumatoid	rheumatoid	NOUN
gra-819	146	14	arthritis	arthritis	NOUN
gra-819	146	15	.	.	PUNCT
gra-819	147	1	arthritis	arthritis	NOUN
gra-819	147	2	rheum	rheum	NOUN
gra-819	147	3	.	.	PUNCT
gra-819	148	1	1974;17:955–63	1974;17:955–63	X
gra-819	148	2	.	.	NOUN
gra-819	148	3	21	21	NUM
gra-819	148	4	.	.	PUNCT
gra-819	148	5	o'driscoll	o'driscoll	PROPN
gra-819	148	6	br	br	PROPN
gra-819	148	7	,	,	PUNCT
gra-819	148	8	milburn	milburn	PROPN
gra-819	148	9	hj	hj	PROPN
gra-819	148	10	,	,	PUNCT
gra-819	148	11	kemeny	kemeny	PROPN
gra-819	148	12	dm	dm	PROPN
gra-819	148	13	,	,	PUNCT
gra-819	148	14	cochrane	cochrane	PROPN
gra-819	148	15	gm	gm	PROPN
gra-819	148	16	,	,	PUNCT
gra-819	148	17	panayi	panayi	PROPN
gra-819	148	18	gs	gs	X
gra-819	148	19	.	.	PROPN
gra-819	148	20	atopy	atopy	NOUN
gra-819	148	21	and	and	CCONJ
gra-819	148	22	rheumatoid	rheumatoid	VERB
gra-819	148	23	arthritis	arthritis	NOUN
gra-819	148	24	.	.	PUNCT
gra-819	149	1	clin	clin	PROPN
gra-819	149	2	allergy	allergy	PROPN
gra-819	149	3	.	.	PUNCT
gra-819	150	1	1985;15:547–53	1985;15:547–53	NUM
gra-819	150	2	.	.	PUNCT
gra-819	151	1	22	22	NUM
gra-819	151	2	.	.	PUNCT
gra-819	152	1	hasan	hasan	PROPN
gra-819	152	2	wu	wu	PROPN
gra-819	152	3	,	,	PUNCT
gra-819	152	4	keaney	keaney	PROPN
gra-819	152	5	np	np	PROPN
gra-819	152	6	,	,	PUNCT
gra-819	152	7	holland	holland	PROPN
gra-819	152	8	cd	cd	PROPN
gra-819	152	9	,	,	PUNCT
gra-819	152	10	kelly	kelly	PROPN
gra-819	152	11	ca	can	AUX
gra-819	152	12	.	.	PUNCT
gra-819	153	1	bronchial	bronchial	ADJ
gra-819	153	2	reactivity	reactivity	NOUN
gra-819	153	3	and	and	CCONJ
gra-819	153	4	airow	airow	NUM
gra-819	153	5	obstruction	obstruction	NOUN
gra-819	153	6	in	in	ADP
gra-819	153	7	rheumatoid	rheumatoid	NOUN
gra-819	153	8	arthritis	arthritis	NOUN
gra-819	153	9	.	.	PUNCT
gra-819	154	1	ann	ann	PROPN
gra-819	154	2	rheum	rheum	PROPN
gra-819	154	3	dis	dis	PROPN
gra-819	154	4	.	.	PUNCT
gra-819	155	1	1994;53:511–4	1994;53:511–4	NUM
gra-819	155	2	.	.	PUNCT
gra-819	156	1	23	23	NUM
gra-819	156	2	.	.	PUNCT
gra-819	157	1	allanore	allanore	PROPN
gra-819	157	2	y	y	PROPN
gra-819	157	3	,	,	PUNCT
gra-819	157	4	hilliquin	hilliquin	NOUN
gra-819	157	5	p	p	NOUN
gra-819	157	6	,	,	PUNCT
gra-819	157	7	coste	coste	NOUN
gra-819	157	8	renoux	renoux	NOUN
gra-819	157	9	m	m	PROPN
gra-819	157	10	,	,	PUNCT
gra-819	157	11	menkès	menkès	PROPN
gra-819	157	12	cj	cj	NOUN
gra-819	157	13	.	.	PUNCT
gra-819	157	14	decreased	decrease	VERB
gra-819	157	15	prevalence	prevalence	NOUN
gra-819	157	16	of	of	ADP
gra-819	157	17	atopy	atopy	NOUN
gra-819	157	18	in	in	ADP
gra-819	157	19	rheumatoid	rheumatoid	NOUN
gra-819	157	20	arthritis	arthritis	NOUN
gra-819	157	21	.	.	PUNCT
gra-819	158	1	lancet	lancet	PROPN
gra-819	158	2	.	.	PUNCT
gra-819	159	1	1998;351:497	1998;351:497	NUM
gra-819	159	2	.	.	X
gra-819	160	1	24	24	NUM
gra-819	160	2	.	.	PUNCT
gra-819	161	1	kumutnart	kumutnart	PROPN
gra-819	161	2	chanprapaph	chanprapaph	PROPN
gra-819	161	3	,	,	PUNCT
gra-819	161	4	wimolsiri	wimolsiri	PROPN
gra-819	161	5	iamsumang	iamsumang	PROPN
gra-819	161	6	,	,	PUNCT
gra-819	161	7	penpun	penpun	NOUN
gra-819	161	8	wattanakrai	wattanakrai	NOUN
gra-819	161	9	,	,	PUNCT
gra-819	161	10	and	and	CCONJ
gra-819	161	11	vasanop	vasanop	ADJ
gra-819	161	12	vachiramon	vachiramon	NOUN
gra-819	161	13	.	.	PUNCT
gra-819	162	1	thyroid	thyroid	NOUN
gra-819	162	2	autoimmunity	autoimmunity	NOUN
gra-819	162	3	and	and	CCONJ
gra-819	162	4	autoimmunity	autoimmunity	NOUN
gra-819	162	5	in	in	ADP
gra-819	162	6	chronic	chronic	ADJ
gra-819	162	7	spontaneous	spontaneous	ADJ
gra-819	162	8	urticaria	urticaria	NOUN
gra-819	162	9	linked	link	VERB
gra-819	162	10	to	to	ADP
gra-819	162	11	disease	disease	NOUN
gra-819	162	12	severity	severity	NOUN
gra-819	162	13	,	,	PUNCT
gra-819	162	14	therapeuticresponse	therapeuticresponse	NOUN
gra-819	162	15	,	,	PUNCT
gra-819	162	16	and	and	CCONJ
gra-819	162	17	time	time	NOUN
gra-819	162	18	to	to	ADP
gra-819	162	19	remission	remission	NOUN
gra-819	162	20	in	in	ADP
gra-819	162	21	patients	patient	NOUN
gra-819	162	22	with	with	ADP
gra-819	162	23	chronic	chronic	ADJ
gra-819	162	24	spontaneous	spontaneous	ADJ
gra-819	162	25	urticaria	urticaria	NOUN
gra-819	162	26	.	.	PUNCT
gra-819	163	1	hindawi	hindawi	PROPN
gra-819	163	2	biomed	biome	VERB
gra-819	163	3	research	research	NOUN
gra-819	163	4	international	international	ADJ
gra-819	163	5	volume	volume	NOUN
gra-819	163	6	2018	2018	NUM
gra-819	163	7	,	,	PUNCT
gra-819	163	8	13	13	NUM
gra-819	163	9	pages	page	NOUN
gra-819	163	10	.	.	PUNCT
gra-819	164	1	volume-8	volume-8	NUM
gra-819	164	2	,	,	PUNCT
gra-819	164	3	issue-11	issue-11	PROPN
gra-819	164	4	,	,	PUNCT
gra-819	164	5	november-2019	november-2019	ADJ
gra-819	164	6	•	•	NOUN
gra-819	164	7	print	print	NOUN
gra-819	164	8	issn	issn	PROPN
gra-819	164	9	no	no	NOUN
gra-819	164	10	.	.	PROPN
gra-819	165	1	2277	2277	NUM
gra-819	165	2	8160	8160	NUM
gra-819	165	3	•	•	NOUN
gra-819	165	4	doi	doi	NOUN
gra-819	165	5	:	:	PUNCT
gra-819	165	6	10.36106	10.36106	NUM
gra-819	165	7	/	/	SYM
gra-819	165	8	gjra	gjra	NOUN
gra-819	165	9	esr	esr	PROPN
gra-819	165	10	age	age	NOUN
gra-819	165	11	0.044	0.044	NUM
gra-819	165	12	ana	ana	PROPN
gra-819	165	13	uas	uas	PROPN
gra-819	165	14	0.000	0.000	NUM
gra-819	165	15	age	age	NOUN
gra-819	165	16	esr	esr	PROPN
gra-819	165	17	0.044	0.044	NUM
gra-819	165	18	esr	esr	PROPN
gra-819	165	19	ana	ana	PROPN
gra-819	165	20	0.026	0.026	NUM
gra-819	165	21	ana	ana	PROPN
gra-819	165	22	esr	esr	PROPN
gra-819	165	23	0.026	0.026	NUM
gra-819	165	24	age	age	NOUN
gra-819	165	25	duration	duration	NOUN
gra-819	165	26	0.000	0.000	NUM
gra-819	165	27	esr	esr	PROPN
gra-819	165	28	antitpo	antitpo	PROPN
gra-819	165	29	antibodies	antibodie	VERB
gra-819	165	30	0.024	0.024	NUM
gra-819	165	31	anti	anti	PROPN
gra-819	165	32	tpo	tpo	PROPN
gra-819	165	33	antibod	antibod	VERB
gra-819	165	34	-	-	PUNCT
gra-819	165	35	ies	ies	NOUN
gra-819	165	36	esr	esr	PROPN
gra-819	165	37	0.024	0.024	NUM
gra-819	165	38	age	age	NOUN
gra-819	165	39	s.	s.	PROPN
gra-819	165	40	ige	ige	PROPN
gra-819	165	41	0.025	0.025	NUM
gra-819	165	42	esr	esr	PROPN
gra-819	165	43	sex	sex	NOUN
gra-819	165	44	(	(	PUNCT
gra-819	165	45	female	female	NOUN
gra-819	165	46	)	)	PUNCT
gra-819	165	47	0.007	0.007	NUM
gra-819	165	48	asst	asst	NOUN
gra-819	165	49	uas	uas	PROPN
gra-819	165	50	0.044	0.044	NUM
gra-819	165	51	sex	sex	NOUN
gra-819	165	52	esr	esr	PROPN
gra-819	165	53	0.007	0.007	NUM
gra-819	165	54	crp	crp	PROPN
gra-819	165	55	uas	uas	NOUN
gra-819	165	56	0.025	0.025	NUM
gra-819	165	57	rf	rf	PROPN
gra-819	165	58	serum	serum	NOUN
gra-819	165	59	ige	ige	PROPN
gra-819	165	60	0.020	0.020	NUM
gra-819	165	61	crp	crp	NOUN
gra-819	165	62	tlc	tlc	NOUN
gra-819	165	63	0.025	0.025	NUM
gra-819	165	64	aec	aec	PROPN
gra-819	165	65	uas	uas	PROPN
gra-819	165	66	0.043	0.043	NUM
gra-819	165	67	aec	aec	PROPN
gra-819	165	68	tlc	tlc	NOUN
gra-819	165	69	0.025	0.025	NUM
gra-819	165	70	46	46	NUM
gra-819	165	71	x	x	SYM
gra-819	165	72	gjra	gjra	ADJ
gra-819	165	73	global	global	ADJ
gra-819	165	74	journal	journal	PROPN
gra-819	165	75	for	for	ADP
gra-819	165	76	research	research	NOUN
gra-819	165	77	analysis	analysis	NOUN